Infection of the lung often accompanied by inflammation.
Inflammation of the lung parenchyma that is caused by bacterial infections.
Inflammation of the lung parenchyma that is caused by a viral infection.
A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS.
Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by cross bacterial infections in hospitals (NOSOCOMIAL INFECTIONS).
A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.
Pneumonia due to aspiration or inhalation of various oily or fatty substances.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
A group of interstitial lung diseases with no known etiology. There are several entities with varying patterns of inflammation and fibrosis. They are classified by their distinct clinical-radiological-pathological features and prognosis. They include IDIOPATHIC PULMONARY FIBROSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; and others.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Substances that reduce the growth or reproduction of BACTERIA.
A species of the genus PNEUMOVIRUS causing pneumonia in mice.
A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.
A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.
An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.
Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.
Any infection which a patient contracts in a health-care institution.
A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
The confinement of a patient in a hospital.
Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity.
Mechanical devices used to produce or assist pulmonary ventilation.
Washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.
Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).
Hospital units providing continuous surveillance and care to acutely ill patients.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
A chronic, clinically mild, infectious pneumonia of PIGS caused by MYCOPLASMA HYOPNEUMONIAE. Ninety percent of swine herds worldwide are infected with this economically costly disease that primarily affects animals aged two to six months old. The disease can be associated with porcine respiratory disease complex. PASTEURELLA MULTOCIDA is often found as a secondary infection.
Infections with bacteria of the genus PSEUDOMONAS.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
The prototype species of PNEUMOCYSTIS infecting the laboratory rat, Rattus norvegicus (RATS). It was formerly called Pneumocystis carinii f. sp. carinii. Other species of Pneumocystis can also infect rats.
Presence of pus in a hollow organ or body cavity.
A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES' DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
Child hospitalized for short term care.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
Pneumonia caused by infections with the genus CHLAMYDIA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.
Endoscopic examination, therapy or surgery of the bronchi.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Bovine respiratory disease found in animals that have been shipped or exposed to CATTLE recently transported. The major agent responsible for the disease is MANNHEIMIA HAEMOLYTICA and less commonly, PASTEURELLA MULTOCIDA or HAEMOPHILUS SOMNUS. All three agents are normal inhabitants of the bovine nasal pharyngeal mucosa but not the LUNG. They are considered opportunistic pathogens following STRESS, PHYSIOLOGICAL and/or a viral infection. The resulting bacterial fibrinous BRONCHOPNEUMONIA is often fatal.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.
Infections with bacteria of the genus KLEBSIELLA.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Infections with bacteria of the genus HAEMOPHILUS.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Disease having a short and relatively severe course.
Pathological processes involving any part of the LUNG.
Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.
Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.
Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Elements of limited time intervals, contributing to particular results or situations.
An infant during the first month after birth.
The period of confinement of a patient to a hospital or other health facility.
Infections with bacteria of the genus PASTEURELLA.
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
A species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.
A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Pneumonia caused by infection with bacteria of the family RICKETTSIACEAE.
A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.
Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.
Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
Infections with species of the genus MYCOPLASMA.
A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.
A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
A procedure involving placement of a tube into the trachea through the mouth or nose in order to provide a patient with oxygen and anesthesia.
Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.
A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
A cattle disease of uncertain cause, probably an allergic reaction.
A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally commensal in the flora of CATTLE and SHEEP. But under conditions of physical or PHYSIOLOGICAL STRESS, it can cause MASTITIS in sheep and SHIPPING FEVER or ENZOOTIC CALF PNEUMONIA in cattle. Its former name was Pasteurella haemolytica.
Inflammation of the BRONCHIOLES.
Exotoxins produced by certain strains of streptococci, particularly those of group A (STREPTOCOCCUS PYOGENES), that cause HEMOLYSIS.
A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
A species of gram-negative bacteria causing MASTITIS; ARTHRITIS; and RESPIRATORY TRACT DISEASES in CATTLE.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Therapy with two or more separate preparations given for a combined effect.
Infections with bacteria of the order ACTINOMYCETALES.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
Virus diseases caused by the ADENOVIRIDAE.
Institutions with an organized medical staff which provide medical care to patients.
Infections with bacteria of the genus ACINETOBACTER.
A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
Infections of the lungs with parasites, most commonly by parasitic worms (HELMINTHS).
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Virus diseases caused by the ORTHOMYXOVIRIDAE.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
Postmortem examination of the body.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS.
The L-isomer of Ofloxacin.
An abnormal elevation of body temperature, usually as a result of a pathologic process.
Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.
Diseases of domestic swine and of the wild boar of the genus Sus.
Non-fatal immersion or submersion in water. The subject is resuscitable.
A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Health care provided to a critically ill patient during a medical emergency or crisis.
Measurable quantity of bacteria in an object, organism, or organism compartment.
Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Inhaling liquid or solids, such as stomach contents, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.
Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Chronic endemic respiratory disease of dairy calves and an important component of bovine respiratory disease complex. It primarily affects calves up to six months of age and the etiology is multifactorial. Stress plus a primary viral infection is followed by a secondary bacterial infection. The latter is most commonly associated with PASTEURELLA MULTOCIDA producing a purulent BRONCHOPNEUMONIA. Sometimes present are MANNHEIMIA HAEMOLYTICA; HAEMOPHILUS SOMNUS and mycoplasma species.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.
The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.
A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), that can cause chronic pneumonia (maedi), mastitis, arthritis, and encephalomyelitis (visna) in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte (PULMONARY ADENOMATOSIS, OVINE). Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE.
Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms.
The number of times an organism breathes with the lungs (RESPIRATION) per unit time, usually per minute.
A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.
The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
A species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.
A disease or state in which death is possible or imminent.
Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment.
Infection with CHLAMYDOPHILA PSITTACI (formerly Chlamydia psittaci), transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations.
Suppurative inflammation of the pleural space.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The oldest recognized genus of the family PASTEURELLACEAE. It consists of several species. Its organisms occur most frequently as coccobacillus or rod-shaped and are gram-negative, nonmotile, facultative anaerobes. Species of this genus are found in both animals and humans.
The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.
A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
Number of deaths of children between one year of age to 12 years of age in a given population.
Parliamentary democracy located between France on the northeast and Portugual on the west and bordered by the Atlantic Ocean and the Mediterranean Sea.
A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.
The middle portion of the pharynx that lies posterior to the mouth, inferior to the SOFT PALATE, and superior to the base of the tongue and EPIGLOTTIS. It has a digestive function as food passes from the mouth into the oropharynx before entering ESOPHAGUS.
Substances elaborated by bacteria that have antigenic activity.
Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Infections with bacteria of the genus STAPHYLOCOCCUS.
Act of listening for sounds within the body.

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. (1/4580)

BACKGROUND: The hyper-IgE syndrome with recurrent infections is a rare immunodeficiency characterized by recurrent skin and pulmonary abscesses and extremely elevated levels of IgE in serum. Associated facial and skeletal features have been recognized, but their frequency is unknown, and the genetic basis of the hyper-IgE syndrome is poorly understood. METHODS: We studied 30 patients with the hyper-IgE syndrome and 70 of their relatives. We took histories, reviewed records, performed physical and dental examinations, took anthropometric measurements, and conducted laboratory studies. RESULTS: Nonimmunologic features of the hyper-IgE syndrome were present in all patients older than eight years. Seventy-two percent had the previously unrecognized feature of failure or delay of shedding of the primary teeth owing to lack of root resorption. Common findings among patients were recurrent fractures (in 57 percent of patients), hyperextensible joints (in 68 percent), and scoliosis (in 76 percent of patients 16 years of age or older). The classic triad of abscesses, pneumonia, and an elevated IgE level was identified in 77 percent of all patients and in 85 percent of those older than eight. In 6 of 23 adults (26 percent), IgE levels declined over time and came closer to or fell within the normal range. Autosomal dominant transmission of the hyper-IgE syndrome was found, but with variable expressivity. Of the 27 relatives at risk for inheriting the hyper-IgE syndrome, 10 were fully affected, 11 were unaffected, and 6 had combinations of mild immunologic, dental, and skeletal features of the hyper-IgE syndrome. CONCLUSIONS: The hyper-IgE syndrome is a multisystem disorder that affects the dentition, the skeleton, connective tissue, and the immune system. It is inherited as a single-locus autosomal dominant trait with variable expressivity.  (+info)

Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice. (2/4580)

The virulence of Cryptococcus neoformans isolates with high and low extracellular proteolytic activity was investigated in mice. No consistent relationship between proteolytic activity and virulence was observed, but isolates derived from one strain were shown to elicit different inflammatory responses.  (+info)

Expression of heat shock protein 72 by alveolar macrophages in hypersensitivity pneumonitis. (3/4580)

The current study was done to look at a possible role of heat shock proteins (HSPs) in hypersensitivity pneumonitis (HP). The specific aims were to determine whether there was a difference in the expression of HSP72 in alveolar macrophages (AMs) between mice challenged with HP antigen and saline-treated control mice and between AMs obtained by bronchoalveolar lavage from 18 patients with HP and 11 normal subjects. The expression of HSP72 was studied under basal conditions and under a mild heat shock. HSP72 expression by AMs in response to in vitro stimulation with Saccharopolyspora rectivirgula was lower in AMs of control mice than in those of HP animals. HSP72 was constitutively expressed in AMs of both normal and HP subjects. Densitometric ratios showed that AMs from normal subjects responded to heat shock with a 39 degrees C-to-37 degrees C ratio of 1.72 +/- 0.18 (mean +/- SE), and AMs from HP patients responded with a ratio of 1.16 +/- 0.16 (P = 0.0377). This decreased induction by additional stress of AMs could lead to an altered immunoregulatory activity and account for the inflammation seen in HP.  (+info)

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. (4/4580)

PURPOSE: To obtain statistical data on the use of high-resolution computed tomography (HRCT) for early detection of pneumonia in febrile neutropenic patients with unknown focus of infection. MATERIALS AND METHODS: One hundred eighty-eight HRCT studies were performed prospectively in 112 neutropenic patients with fever of unknown origin persisting for more than 48 hours despite empiric antibiotic treatment. Fifty-four of these studies were performed in transplant recipients. All patients had normal chest roentgenograms. If pneumonia was detected by HRCT, guided bronchoalveolar lavage was recommended. Evidence of pneumonia on chest roentgenograms during follow-up and micro-organisms detected during follow-up were regarded as documentation of pneumonia. RESULTS: Of the 188 HRCT studies, 112 (60%) showed pneumonia and 76 were normal. Documentation of pneumonia was possible in 61 cases by chest roentgenography or micro-organism detection (54%) (P < 10(-6)). Sensitivity of HRCT was 87% (88% in transplant recipients), specificity was 57% (67%), and the negative predictive value was 88% (97%). A time gain of 5 days was achieved by the additional use of HRCT compared to an exclusive use of chest roentgenography. CONCLUSION: The high frequency of inflammatory pulmonary disease after a suspicious HRCT scan (> 50%) proves that pneumonia is not excluded by a normal chest roentgenogram. Given the significantly longer duration of febrile episodes in transplant recipients, HRCT findings are particularly relevant in this subgroup. Patients with normal HRCT scans, particularly transplant recipients, have a low risk of pneumonia during follow-up. All neutropenic patients with fever of unknown origin and normal chest roentgenograms should undergo HRCT.  (+info)

Blastomycosis acquired occupationally during prairie dog relocation--Colorado, 1998. (5/4580)

On August 31, 1998, two suspected cases of fungal pneumonia were reported to the Boulder County (Colorado) Health Department (BCHD). Both patients were immunocompetent, otherwise healthy adults working for the City of Boulder Open Space (CBOS) program on a prairie dog relocation project. This report summarizes the epidemiologic investigation by BCHD, the Colorado Department of Public Health and Environment, and CDC; the findings indicate that these two persons acquired blastomycosis in Colorado, which is outside the area where the disease is endemic.  (+info)

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. (6/4580)

Interleukin (IL)-13 is a pleiotropic cytokine produced in large quantities by activated CD4(+) Th2 lymphocytes. To define further its potential in vivo effector functions, the Clara cell 10-kDa protein promoter was used to express IL-13 selectively in the lung, and the phenotype of the resulting transgenic mice was characterized. In contrast to transgene-negative littermates, the lungs of transgene-positive mice contained an inflammatory response around small and large airways and in the surrounding parenchyma. It was mononuclear in nature and contained significant numbers of eosinophils and enlarged and occasionally multinucleated macrophages. Airway epithelial cell hypertrophy, mucus cell metaplasia, the hyperproduction of neutral and acidic mucus, the deposition of Charcot-Leyden-like crystals, and subepithelial airway fibrosis were also prominently noted. Eotaxin protein and mRNA were also present in large quantities in the lungs of the transgene-positive, but not the transgene-negative, mice. IL-4, IL-5, granulocyte-macrophage colony-stimulating factor, and monocyte chemoattractant protein-5 were not similarly detected. Physiological evaluations revealed significant increases in baseline airways resistance and airways hyperresponsiveness (AHR) to methacholine in transgene-positive animals. Thus, the targeted pulmonary expression of IL-13 causes a mononuclear and eosinophilic inflammatory response, mucus cell metaplasia, the deposition of Charcot-Leyden-like crystals, airway fibrosis, eotaxin production, airways obstruction, and nonspecific AHR. IL-13 may play an important role in the pathogenesis of similar responses in asthma or other Th2-polarized tissue responses.  (+info)

Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation. (7/4580)

The expression of inflammatory mediators by various cells following in vitro CD40 ligation is well known. However, knowledge of the role and interaction with these cells in the establishment and maintenance of in vivo immune-mediated inflammation is limited. In this report, a chimeric mouse model based on CD40 knockout and wild-type mice was used to assess the role of bone marrow (BM)-derived and non-BM-derived cells in a CD40-mediated pulmonary inflammation response. CD40+ BM-derived cells were required for initial cell recruitment, pulmonary edema, and weight loss associated with this response. The structural CD40+ non-BM-derived cells of the lung, such as fibroblasts, epithelial cells, and endothelial cells, could not by themselves establish any level of pulmonary inflammation. However, both the CD40+ BM-derived cells and the structural CD40+ non-BM-derived cells of the lung were required to maximize the level of pulmonary inflammation. Both B cells and T cells played a contributing role in macrophage recruitment and pulmonary edema but neither contributed to the inflammation-associated weight loss. These experiments indicate that CD40+ BM-derived cells were critical to the induction of pulmonary inflammation and that alveolar macrophages, B cells, and T cells contributed to selective aspects of the response.  (+info)

Long-term morbidity and mortality following hypoxaemic lower respiratory tract infection in Gambian children. (8/4580)

Acute lower respiratory infections (ALRI) are the main cause of death in young children worldwide. We report here the results of a study to determine the long-term survival of children admitted to hospital with severe pneumonia. The study was conducted on 190 Gambian children admitted to hospital in 1992-94 for ALRI who survived to discharge. Of these, 83 children were hypoxaemic and were treated with oxygen, and 107 were not. On follow-up in 1996-97, 62% were traced. Of the children with hypoxaemia, 8 had died, compared with 4 of those without. The mortality rates were 4.8 and, 2.2 deaths per 100 child-years of follow-up for hypoxaemic and non-hypoxaemic children, respectively (P = 0.2). Mortality was higher for children who had been malnourished (Z-score < -2) when seen in hospital (rate ratio = 3.2; 95% confidence interval (CI) = 1.03-10.29; P = 0.045). Children with younger siblings experienced less frequent subsequent respiratory infections (rate ratio for further hospitalization with respiratory illness = 0.15; 95% CI = 0.04-0.50; P = 0.002). Children in Gambia who survive hospital admission with hypoxaemic pneumonia have a good prognosis. Survival depends more on nutritional status than on having been hypoxaemic. Investment in oxygen therapy appears justified, and efforts should be made to improve nutrition in malnourished children with pneumonia.  (+info)

Symptoms of pneumonia may include cough, fever, chills, difficulty breathing, and chest pain. In severe cases, pneumonia can lead to respiratory failure, sepsis, and even death.

There are several types of pneumonia, including:

1. Community-acquired pneumonia (CAP): This type of pneumonia is caused by bacteria or viruses and typically affects healthy people outside of hospitals.
2. Hospital-acquired pneumonia (HAP): This type of pneumonia is caused by bacteria or fungi and typically affects people who are hospitalized for other illnesses or injuries.
3. Aspiration pneumonia: This type of pneumonia is caused by food, liquids, or other foreign matter being inhaled into the lungs.
4. Pneumocystis pneumonia (PCP): This type of pneumonia is caused by a fungus and typically affects people with weakened immune systems, such as those with HIV/AIDS.
5. Viral pneumonia: This type of pneumonia is caused by viruses and can be more common in children and young adults.

Pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment may involve antibiotics, oxygen therapy, and supportive care to manage symptoms and help the patient recover. In severe cases, hospitalization may be necessary to provide more intensive care and monitoring.

Prevention of pneumonia includes vaccination against certain types of bacteria and viruses, good hygiene practices such as frequent handwashing, and avoiding close contact with people who are sick. Early detection and treatment can help reduce the risk of complications and improve outcomes for those affected by pneumonia.

The most common bacteria that cause pneumonia are Streptococcus pneumoniae (also known as pneumococcus), Haemophilus influenzae, and Staphylococcus aureus. These bacteria can infect the lungs through various routes, including respiratory droplets, contaminated food or water, or direct contact with an infected person.

Symptoms of pneumonia may include cough, fever, chills, shortness of breath, and chest pain. In severe cases, pneumonia can lead to serious complications such as respiratory failure, sepsis, and death.

Diagnosis of pneumonia typically involves a physical examination, medical history, and diagnostic tests such as chest X-rays or blood cultures. Treatment typically involves antibiotics to eliminate the infection, as well as supportive care to manage symptoms and prevent complications. Vaccines are also available to protect against certain types of bacterial pneumonia, particularly in children and older adults.

Preventative measures for bacterial pneumonia include:

* Getting vaccinated against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib)
* Practicing good hygiene, such as washing hands regularly and covering the mouth and nose when coughing or sneezing
* Avoiding close contact with people who are sick
* Staying hydrated and getting enough rest
* Quitting smoking, if applicable
* Managing underlying medical conditions, such as diabetes or heart disease

It is important to seek medical attention promptly if symptoms of pneumonia develop, particularly in high-risk populations. Early diagnosis and treatment can help prevent serious complications and improve outcomes for patients with bacterial pneumonia.

A type of pneumonia caused by a viral infection. The most common viruses that cause pneumonia are the respiratory syncytial virus (RSV), influenza virus, and adenovirus.

Symptoms include fever, cough, chest pain, difficulty breathing, and loss of appetite.

Treatment typically involves antiviral medications and supportive care to manage symptoms and improve lung function. In severe cases, hospitalization may be necessary.

Prevention measures include vaccination against the flu and RSV, good hygiene practices such as frequent handwashing, and avoiding close contact with people who are sick.

Symptoms of pneumococcal pneumonia can include fever, cough, chest pain, shortness of breath, and difficulty breathing. In severe cases, the infection can spread to the bloodstream and cause sepsis, a life-threatening condition that requires immediate medical attention.

Pneumococcal pneumonia is most commonly seen in young children, older adults, and people with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive medications. It is usually diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays and blood cultures.

Treatment of pneumococcal pneumonia typically involves antibiotics to eliminate the bacterial infection. In severe cases, hospitalization may be necessary to provide oxygen therapy, fluid replacement, and other supportive care. Vaccines are also available to prevent Streptococcus pneumoniae infections, particularly in children and older adults.

Prevention measures for pneumococcal pneumonia include:

* Vaccination: The pneumococcal conjugate vaccine (PCV) is recommended for children under the age of 2 and older adults over the age of 65, as well as for people with certain medical conditions.
* Good hygiene: Regular handwashing and avoiding close contact with people who are sick can help prevent the spread of the infection.
* Avoiding smoking: Smoking can damage the lungs and increase the risk of infection.
* Keeping up-to-date on recommended vaccinations: Staying current on recommended vaccinations, such as the flu shot, can help prevent secondary bacterial infections like pneumococcal pneumonia.
* Managing underlying conditions: People with certain medical conditions, such as diabetes or chronic lung disease, should work with their healthcare provider to manage their condition and reduce their risk of developing pneumococcal pneumonia.

It's important to seek medical attention right away if you or someone you know is experiencing symptoms of pneumococcal pneumonia, as early treatment can help prevent complications and improve outcomes.

COP typically affects middle-aged adults and is more common in women than men. Symptoms include cough, shortness of breath, fever, and fatigue. The condition can be acute or chronic, and it can lead to respiratory failure if left untreated.

The exact cause of COP is not known, but it is believed to be related to an abnormal immune response to environmental triggers, such as cigarette smoke or other inhaled substances. The disease is often associated with other autoimmune disorders, such as rheumatoid arthritis or lupus.

Diagnosis of COP is based on a combination of clinical findings, radiologic imaging (such as chest x-rays and CT scans), and lung biopsy. Treatment typically involves corticosteroids to reduce inflammation and improve lung function. In severe cases, respiratory support may be necessary.

The prognosis for COP varies depending on the severity of the disease and the response to treatment. In general, the condition can be managed with appropriate therapy, but it can be challenging to diagnose and treat effectively.

This type of pneumonia can cause severe respiratory symptoms, including cough, fever, chest pain, and difficulty breathing. It can also lead to respiratory failure and other complications if left untreated.

Pneumocystis pneumonia is diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or CT scans, and blood tests. Treatment typically involves antifungal medications, and hospitalization may be necessary for severe cases.

Prevention measures include avoiding exposure to people with weakened immune systems, avoiding smoking, and maintaining good hygiene practices. Vaccines are also available for some populations at high risk of developing Pneumocystis pneumonia.

Staphylococcal pneumonia is an infection of the lungs that occurs when the bacteria enter the lungs and cause inflammation. This condition can be particularly dangerous for certain groups of people, such as children under the age of two, adults over the age of 65, and those with weakened immune systems or chronic medical conditions.

The symptoms of staphylococcal pneumonia can vary depending on the severity of the infection, but they may include:

* Fever and chills
* Cough, which may be dry or produce mucus
* Chest pain that worsens with deep breathing or coughing
* Shortness of breath
* Headache
* Muscle aches and fatigue
* Confusion or disorientation in older adults

Staphylococcal pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment typically involves antibiotics, which can help clear the infection and reduce symptoms. In severe cases, hospitalization may be necessary to provide supportive care, such as oxygen therapy or mechanical ventilation.

Prevention of staphylococcal pneumonia is key, and this includes:

* Vaccination: The pneumococcal conjugate vaccine (PCV) is recommended for children under the age of two and adults over the age of 65, as well as those with certain medical conditions.
* Good hygiene practices: Washing hands regularly, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick can help prevent the spread of the bacteria.
* Avoiding risky behaviors: Avoiding sharing personal items, such as toothbrushes or drinking glasses, and not engaging in risky behaviors like unprotected sex or sharing needles can also help prevent the spread of the bacteria.

It is important to seek medical attention if you or a loved one is experiencing symptoms of pneumonia, as early treatment can help prevent complications and improve outcomes.

VAP is a serious complication of mechanical ventilation and can lead to severe illness, organ failure, and death. The risk of developing VAP is increased in patients who are ventilated for longer periods of time, have underlying medical conditions such as chronic obstructive pulmonary disease (COPD) or sepsis, or have invasive medical devices such as central lines or urinary catheters.

The diagnosis of VAP is based on a combination of clinical and laboratory findings, including fever, purulent respiratory secretions, and evidence of lung infection on chest radiographs or computed tomography (CT) scans. Treatment typically involves administration of broad-spectrum antibiotics and supportive care, such as mechanical ventilation and fluid management.

Prevention of VAP is an important goal in critical care medicine, and strategies to reduce the risk of developing VAP include:

1. Early recognition and treatment of respiratory tract infections
2. Proper hand hygiene and use of personal protective equipment (PPE) by healthcare workers
3. Regular cleaning and disinfection of medical devices and equipment
4. Use of selective digestive decontamination (SDD) with antibiotics and probiotics to reduce the risk of colonization of the respiratory tract by pathogenic bacteria
5. Avoiding invasive medical procedures whenever possible, and using alternative methods when feasible.

The incidence of VAP has been declining in recent years due to improved infection control practices and the use of evidence-based guidelines for prevention and treatment. However, VAP remains a significant challenge in critical care medicine, and ongoing research is needed to develop more effective strategies for prevention and treatment.

The symptoms of aspiration pneumonia may include cough, fever, chills, difficulty breathing, and chest pain. The infection can be mild, moderate, or severe and can affect people of all ages, but it is more common in older adults or those with underlying medical conditions.

The diagnosis of aspiration pneumonia is usually made based on a combination of physical examination findings, medical history, and diagnostic tests such as chest x-rays or CT scans. Treatment typically involves antibiotics and supportive care such as oxygen therapy and mechanical ventilation in severe cases. In some cases, hospitalization may be required to monitor and treat the infection.

Prevention of aspiration pneumonia includes avoiding eating or drinking before lying down, taking small bites and chewing food thoroughly, and avoiding alcohol and sedatives. It is also important to maintain good oral hygiene and to avoid smoking and other forms of tobacco use. Vaccination against certain types of pneumonia may also be recommended for some individuals at high risk.

Examples of CAIs include:

1. Respiratory infections such as bronchitis, pneumonia, and influenza.
2. Skin and soft tissue infections such as cellulitis, abscesses, and wound infections.
3. Gastrointestinal infections such as food poisoning, diarrhea, and gastroenteritis.
4. Urinary tract infections (UTIs) caused by bacteria that enter the urinary tract through the urethra or bladder.
5. Sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.
6. Bacterial infections such as staphylococcus aureus, streptococcus pneumoniae, and haemophilus influenzae.
7. Viral infections such as herpes simplex virus (HSV), human papillomavirus (HPV), and norovirus.

CAIs can be treated with antibiotics, antivirals, or other medications depending on the cause of the infection. It's important to seek medical attention if symptoms persist or worsen over time, as untreated CAIs can lead to serious complications and potentially life-threatening conditions.

Symptoms:

* Fever
* Cough
* Chest pain or tightness
* Shortness of breath
* Headache
* Muscle aches
* Fatigue

Diagnosis:

* Physical examination
* Complete blood count (CBC)
* Blood cultures
* Chest X-ray
* Polymerase chain reaction (PCR)

Treatment:

* Antibiotics (macrolides, fluoroquinolones, and aminoglycosides)
* Supportive care (fluids, oxygen therapy, pain management)

Prevention:

* Vaccination (not available in the US)
* Good hand hygiene
* Avoiding close contact with people who are sick

Prognosis:

* Most cases of Mycoplasma pneumoniae pneumonia are mild and resolve quickly with antibiotic treatment.
* In severe cases, the infection can spread to other parts of the body and cause serious complications such as respiratory failure, sepsis, and meningitis.

Epidemiology:

* Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) worldwide.
* It is more common in children than adults.
* The incidence of Mycoplasma pneumoniae infection varies by age, with the highest incidence in children under 5 years old.

The symptoms of lipid pneumonia can be similar to those of other types of pneumonia, such as cough, fever, chills, and difficulty breathing. However, lipid pneumonia may also cause a distinctive "fatty" or "oily" appearance on chest X-rays.

There are several possible causes of lipid pneumonia, including inhalation of lipids from the environment or from certain medical procedures (such as intratracheal lipid injections), and certain underlying medical conditions (such as cystic fibrosis). The diagnosis of lipid pneumonia is typically made through a combination of clinical evaluation, chest X-rays, and laboratory tests.

Treatment of lipid pneumonia usually involves supportive care measures such as oxygen therapy, hydration, and pain management, as well as antibiotics to prevent or treat any underlying bacterial infections. In severe cases, hospitalization may be necessary to monitor and treat the condition.

Prognosis for lipid pneumonia is generally good if treated promptly and effectively, but the condition can be serious and potentially life-threatening if left untreated or if there are underlying medical conditions that complicate treatment.

Examples of lung diseases, interstitial include:

1. Idiopathic pulmonary fibrosis (IPF): A chronic and progressive disease characterized by inflammation and scarring of the lungs without a known cause.
2. Sarcoidosis: A systemic disease characterized by inflammation and granulomas in various organs, including the lungs.
3. Hypersensitivity pneumonitis (HP): An immune-mediated reaction to inhaled antigens that can lead to inflammation and scarring of the lungs.
4. Pneumoconiosis: A group of lung diseases caused by inhaling dust, including asbestos, silica, and coal dust.
5. Desquamative interstitial pneumonitis (DIP): A rare disease characterized by progressive inflammation and scarring of the lungs.
6. Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD): A rare disease caused by inflammation and scarring of the small airways and surrounding tissue.
7. Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): A sudden worsening of IPF symptoms, often accompanied by inflammation and scarring of the lungs.

Symptoms of lung diseases, interstitial can include:

1. Shortness of breath (dyspnea)
2. Cough
3. Fatigue
4. Chest tightness or pain
5. Dry cough
6. Weight loss
7. Fever

Diagnosis is typically made through a combination of physical examination, medical history, laboratory tests (such as blood tests and lung function tests), and imaging studies (such as chest X-rays and computed tomography (CT) scans).

Treatment options for interstitial lung disease depend on the specific diagnosis and severity of the condition. These may include:

1. Medications to reduce inflammation and prevent further scarring, such as corticosteroids or immunosuppressants.
2. Oxygen therapy to help improve oxygen levels in the blood.
3. Pulmonary rehabilitation to improve lung function and overall health.
4. Surgical procedures, such as lung transplantation, in severe cases where other treatments have failed.
5. Lifestyle changes, such as quitting smoking and avoiding exposure to dust and pollutants.

There are several types of IIPs, including:

1. Idiopathic pulmonary fibrosis (IPF): This is the most common and severe form of IIP, characterized by progressive lung scarring and difficulty breathing.
2. Usual interstitial pneumonia (UIP): This type of IIP is similar to IPF but has a more variable course and may have a better prognosis.
3. Crystal-associated pulmonary fibrosis: This type of IIP is caused by the accumulation of crystals in the lungs, leading to inflammation and scarring.
4. Desquamative interstitial pneumonia (DIP): This type of IIP is characterized by the loss of the lung tissue's outer layer, leading to inflammation and scarring.
5. Acid-fast bacillus-associated interstitial pneumonia: This type of IIP is caused by infection with a specific type of bacteria, known as acid-fast bacilli.

The symptoms of IIPs can vary depending on the specific type and severity of the disease, but may include:

* Difficulty breathing
* Shortness of breath
* Cough
* Chest tightness or pain
* Fatigue
* Weight loss

The exact cause of IIPs is not known, but it is believed to involve a combination of genetic and environmental factors. The diagnosis of IIP is based on a combination of clinical symptoms, physical examination findings, and results of diagnostic tests such as chest X-rays, CT scans, and lung biopsy.

Treatment for IIPs is aimed at managing symptoms and slowing the progression of the disease. This may include medications to reduce inflammation and improve breathing, oxygen therapy, and in severe cases, lung transplantation. Early diagnosis and treatment are important to improve outcomes for patients with IIPs.

Legionnaires' disease is typically acquired by inhaling aerosolized water droplets contaminated with Legionella bacteria. The most common sources of exposure are cooling towers, hot tubs, and plumbing systems in large buildings. The risk of infection increases with age, and people with weakened immune systems, such as those with cancer, HIV/AIDS, or chronic lung disease, are at greater risk for severe illness and death.

The symptoms of Legionnaires' disease can resemble those of pneumonia and include fever, chills, cough, muscle aches, and shortness of breath. In severe cases, the disease can lead to respiratory failure, septic shock, and even death.

Legionnaires' disease is diagnosed through a combination of physical examination, medical history, and laboratory tests, including blood cultures and urinary antigen tests. Treatment typically involves antibiotics, which can be effective if started early in the course of the illness. In severe cases, hospitalization may be required to provide supportive care, such as mechanical ventilation.

Prevention is key to avoiding Legionnaires' disease, and this includes regularly cleaning and disinfecting cooling towers and plumbing systems, maintaining proper water temperatures, and ensuring that the system is properly designed and maintained. Testing for Legionella bacteria can also be performed to ensure that the system is free of contamination.

In summary, Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila, typically acquired through inhalation of contaminated aerosolized water droplets. Early diagnosis and treatment are critical to preventing severe illness and death, and prevention measures include regular cleaning and maintenance of cooling towers and plumbing systems, as well as testing for Legionella bacteria.

In medicine, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure. This type of transmission can occur in various settings, such as hospitals, clinics, and long-term care facilities, where patients with compromised immune systems are more susceptible to infection.

Cross-infection can occur through a variety of means, including:

1. Person-to-person contact: Direct contact with an infected individual, such as touching, hugging, or shaking hands.
2. Contaminated surfaces and objects: Touching contaminated surfaces or objects that have been touched by an infected individual, such as doorknobs, furniture, or medical equipment.
3. Airborne transmission: Inhaling droplets or aerosolized particles that contain the infectious agent, such as during coughing or sneezing.
4. Contaminated food and water: Consuming food or drinks that have been handled by an infected individual or contaminated with the infectious agent.
5. Insect vectors: Mosquitoes, ticks, or other insects can transmit infections through their bites.

Cross-infection is a significant concern in healthcare settings, as it can lead to outbreaks of nosocomial infections (infections acquired in hospitals) and can spread rapidly among patients, healthcare workers, and visitors. To prevent cross-infection, healthcare providers use strict infection control measures, such as wearing personal protective equipment (PPE), thoroughly cleaning and disinfecting surfaces, and implementing isolation precautions for infected individuals.

In summary, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure in healthcare settings. Preventing cross-infection is essential to maintaining a safe and healthy environment for patients, healthcare workers, and visitors.

The diagnosis of pulmonary eosinophilia is based on a combination of clinical symptoms, physical examination findings, and laboratory tests such as chest X-rays, blood tests, and bronchoalveolar lavage (BAL) fluid analysis.

Treatment of pulmonary eosinophilia depends on the underlying cause and may include medications such as corticosteroids, antihistamines, or antibiotics, as well as lifestyle modifications such as avoiding allergens and managing stress. In severe cases, hospitalization may be necessary to monitor and treat the condition.

Some common symptoms of pulmonary eosinophilia include:

* Coughing
* Shortness of breath (dyspnea)
* Chest tightness or discomfort
* Fatigue
* Wheezing
* Recurrent respiratory infections

Complications of pulmonary eosinophilia can include:

* Respiratory failure
* Asthma exacerbation
* Chronic obstructive pulmonary disease (COPD)
* Pneumonia or other respiratory infections
* Airway obstruction

It is important to seek medical attention if you experience any of these symptoms, as early diagnosis and treatment can help prevent complications and improve outcomes.

Bronchopneumonia is a serious condition that can lead to respiratory failure and other complications if left untreated. It is important for individuals with bronchopneumonia to seek medical attention promptly if they experience any worsening symptoms or signs of infection, such as increased fever or difficulty breathing.

Bronchopneumonia can be caused by a variety of factors, including bacterial and viral infections, and can affect individuals of all ages. It is most common in young children and the elderly, as well as those with pre-existing respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD).

Treatment for bronchopneumonia typically involves antibiotics to treat any bacterial infections, as well as supportive care to help manage symptoms and improve lung function. In severe cases, hospitalization may be necessary to provide more intensive treatment and monitoring.

In addition to antibiotics and supportive care, other treatments for bronchopneumonia may include:

* Oxygen therapy to help increase oxygen levels in the blood
* Pain management medications to relieve chest pain and fever
* Breathing exercises and pulmonary rehabilitation to improve lung function
* Rest and relaxation to help the body recover

Prevention is key in avoiding bronchopneumonia, and this can be achieved through:

* Good hand hygiene and respiratory etiquette
* Avoiding close contact with individuals who are sick
* Getting vaccinated against pneumococcal disease and the flu
* Practicing good hygiene during travel to avoid exposure to respiratory infections.

In conclusion, bronchopneumonia is a serious condition that can be caused by a variety of factors and can affect individuals of all ages. Treatment typically involves antibiotics and supportive care, and prevention strategies include good hygiene practices and vaccination. With proper treatment and care, individuals with bronchopneumonia can recover and lead active lives.

The disease progresses rapidly and can cause severe respiratory distress, fever, and weight loss in affected animals. Pneumonia, Progressive Interstitial, of Sheep is often fatal if left untreated, so early detection and aggressive treatment are important to prevent illness and death.

The symptoms of Pneumonia, Progressive Interstitial, of Sheep can include:

* Coughing and difficulty breathing
* Fever
* Loss of appetite and weight loss
* Blue discoloration of the skin and mucous membranes (cyanosis)
* Labored breathing
* Difficulty standing or walking

The diagnosis of Pneumonia, Progressive Interstitial, of Sheep is typically made based on a combination of clinical signs, physical examination, and laboratory tests such as blood cultures or PCR (polymerase chain reaction) testing.

Treatment of Pneumonia, Progressive Interstitial, of Sheep typically involves the use of antibiotics to control the infection, as well as supportive care such as fluids, oxygen therapy, and medication to manage fever and respiratory distress. In severe cases, hospitalization may be necessary to provide more intensive care.

Prevention of Pneumonia, Progressive Interstitial, of Sheep includes the use of vaccination, good husbandry practices such as providing clean water and adequate nutrition, and avoiding contact with other animals that may be infected with the disease.

Synonyms: Mycoplasmosis, Enzootic pneumonia of swine, Swine pneumonia, Hypoxemia, Air sac disease.

Note: This definition is an extract from the medical literature and may not be entirely comprehensive or up to date. For more detailed information, please consult a qualified healthcare professional.

Pseudomonas infections are challenging to treat due to the bacteria's ability to develop resistance against antibiotics. The treatment typically involves a combination of antibiotics and other supportive therapies, such as oxygen therapy or mechanical ventilation, to manage symptoms and prevent complications. In some cases, surgical intervention may be necessary to remove infected tissue or repair damaged organs.

Empyema can be classified into two types:

1. Pyopneumothorax: This type of empyema is caused by a bacterial infection that spreads to the pleural space and causes pus to accumulate.
2. Chemical pneumonitis: This type of empyema is caused by exposure to chemical irritants, such as smoke or chemical fumes, which can damage the lungs and cause inflammation and pus accumulation in the pleural space.

Symptoms of empyema may include chest pain, fever, coughing up pus, and difficulty breathing. Treatment options for empyema depend on the severity of the condition and may include antibiotics, chest tubes, or surgery to drain the pus from the pleural space.

Empyema is a serious medical condition that can lead to complications such as respiratory failure, sepsis, and lung damage if left untreated. Prompt diagnosis and treatment are essential to prevent these complications and improve outcomes for patients with empyema.

Symptoms of influenza include:

* Fever (usually high)
* Cough
* Sore throat
* Runny or stuffy nose
* Headache
* Muscle or body aches
* Fatigue (tiredness)
* Diarrhea and nausea (more common in children than adults)

Influenza can lead to serious complications, such as pneumonia, bronchitis, and sinus and ear infections. These complications are more likely to occur in people who have a weakened immune system, such as the elderly, young children, and people with certain chronic health conditions (like heart disease, diabetes, and lung disease).

Influenza is diagnosed based on a physical examination and medical history. A healthcare provider may also use a rapid influenza test (RIT) or a polymerase chain reaction (PCR) test to confirm the diagnosis.

Treatment for influenza typically involves rest, hydration, and over-the-counter medications such as acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) to relieve fever and body aches. Antiviral medications, such as oseltamivir (Tamiflu) or zanamivir (Relenza), may also be prescribed to help shorten the duration and severity of the illness. However, these medications are most effective when started within 48 hours of the onset of symptoms.

Prevention is key in avoiding influenza. Vaccination is the most effective way to prevent influenza, as well as practicing good hygiene such as washing your hands frequently, avoiding close contact with people who are sick, and staying home when you are sick.

Types of Pneumococcal Infections:

1. Pneumonia: This is an infection of the lungs that can cause fever, cough, chest pain, and difficulty breathing.
2. Meningitis: This is an infection of the membranes that cover the brain and spinal cord, which can cause fever, headache, stiff neck, and confusion.
3. Septicemia (bloodstream infection): This is an infection of the blood that can cause fever, chills, and low blood pressure.
4. Sinusitis: This is an infection of the sinuses, which can cause headache, facial pain, and difficulty breathing through the nose.
5. Otitis media (middle ear infection): This is an infection of the middle ear, which can cause ear pain, fever, and hearing loss.

Causes and Risk Factors:

Pneumococcal infections are caused by the bacteria Streptococcus pneumoniae. These bacteria can be spread through close contact with an infected person, such as touching or sharing food and drinks. People who are at high risk for developing pneumococcal infections include:

1. Children under the age of 5 and adults over the age of 65.
2. People with weakened immune systems, such as those with cancer, HIV/AIDS, or taking medications that suppress the immune system.
3. Smokers and people with chronic respiratory diseases, such as asthma or chronic obstructive pulmonary disease (COPD).
4. People who have recently had surgery or have a severe injury.
5. Those who live in long-term care facilities or have limited access to healthcare.

Prevention and Treatment:

Preventing pneumococcal infections is important, especially for high-risk individuals. Here are some ways to prevent and treat pneumococcal infections:

1. Vaccination: The pneumococcal conjugate vaccine (PCV) is recommended for children under the age of 5 and adults over the age of 65, as well as for people with certain medical conditions.
2. Hand washing: Frequent hand washing can help prevent the spread of pneumococcal bacteria.
3. Good hygiene: Avoiding close contact with people who are sick and regularly cleaning surfaces that may be contaminated with bacteria can also help prevent infection.
4. Antibiotics: Pneumococcal infections can be treated with antibiotics, but overuse of antibiotics can lead to the development of antibiotic-resistant bacteria. Therefore, antibiotics should only be used when necessary and under the guidance of a healthcare professional.
5. Supportive care: Those with severe pneumococcal infections may require hospitalization and supportive care, such as oxygen therapy or mechanical ventilation.

Conclusion:

Pneumococcal infections can be serious and even life-threatening, especially for high-risk individuals. Prevention and prompt treatment are key to reducing the risk of complications and improving outcomes. Vaccination, good hygiene practices, and appropriate antibiotic use are all important in preventing and treating pneumococcal infections. If you suspect that you or a loved one has a pneumococcal infection, it is essential to seek medical attention right away. With proper care and support, many people with pneumococcal infections can recover fully and resume their normal lives.

Symptoms of chlamydial pneumonia can include fever, cough, chest pain, difficulty breathing, and fatigue. In severe cases, the infection can progress to respiratory failure, pneumonia, and even death.

Diagnosis of chlamydial pneumonia typically involves a combination of physical examination, medical history, and laboratory tests such as blood tests or polymerase chain reaction (PCR) tests to detect the presence of the bacteria in the body.

Treatment of chlamydial pneumonia usually involves antibiotics, which can help clear the infection and alleviate symptoms. In severe cases, hospitalization may be necessary to provide supportive care, such as oxygen therapy and mechanical ventilation.

Prevention of chlamydial pneumonia includes vaccination, good hygiene practices, and avoiding close contact with people who are infected with the bacteria. Vaccines are available for certain populations, such as children and adults who are at high risk of infection.

In conclusion, chlamydial pneumonia is a serious bacterial infection that can cause severe symptoms and complications if left untreated. Early diagnosis and prompt treatment with antibiotics can help to alleviate symptoms and prevent complications. Prevention measures such as vaccination and good hygiene practices can also help reduce the risk of infection.

Bacteremia can occur when bacteria enter the bloodstream through various means, such as:

* Infected wounds or surgical sites
* Injecting drug use
* Skin infections
* Respiratory tract infections
* Urinary tract infections
* Endocarditis (infection of the heart valves)

The symptoms of bacteremia can vary depending on the type of bacteria and the severity of the infection. Some common symptoms include:

* Fever
* Chills
* Headache
* Muscle aches
* Weakness
* Confusion
* Shortness of breath

Bacteremia is diagnosed by blood cultures, which involve collecting blood samples and inserting them into a specialized container to grow the bacteria. Treatment typically involves antibiotics and supportive care, such as intravenous fluids and oxygen therapy. In severe cases, hospitalization may be necessary to monitor and treat the infection.

Prevention measures for bacteremia include:

* Practicing good hygiene, such as washing hands regularly
* Avoiding sharing personal items like toothbrushes or razors
* Properly cleaning and covering wounds
* Getting vaccinated against infections that can lead to bacteremia
* Following proper sterilization techniques during medical procedures

Overall, bacteremia is a serious condition that requires prompt medical attention to prevent complications and ensure effective treatment.

Examples of AROIs include:

1. Pneumocystis pneumonia (PCP): a type of pneumonia caused by the fungus Pneumocystis jirovecii.
2. Tuberculosis (TB): a bacterial infection that can affect the lungs, brain, or other organs.
3. Toxoplasmosis: an infection caused by the parasite Toxoplasma gondii that can affect the brain, eyes, and other organs.
4. Cryptococcosis: a fungal infection that can affect the lungs, brain, or skin.
5. Histoplasmosis: a fungal infection caused by Histoplasma capsulatum that can affect the lungs, skin, and other organs.
6. Aspergillosis: a fungal infection caused by Aspergillus species that can affect the lungs, sinuses, and other organs.
7. Candidiasis: a fungal infection caused by Candida species that can affect the mouth, throat, vagina, or skin.
8. Kaposi's sarcoma: a type of cancer that is caused by the human herpesvirus 8 (HHV-8) and can affect the skin and lymph nodes.
9. Wasting syndrome: a condition characterized by weight loss, fatigue, and diarrhea.
10. Opportunistic infections that can affect the gastrointestinal tract, such as cryptosporidiosis and isosporiasis.

AROIs are a major cause of morbidity and mortality in individuals with HIV/AIDS, and they can be prevented or treated with antimicrobial therapy, supportive care, and other interventions.

The symptoms of pneumonic pasteurellosis in humans include fever, cough, chest pain, and difficulty breathing. In severe cases, the infection can lead to respiratory failure, sepsis, and death.

Pasteurellosis, Pneumonic is diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood cultures and chest x-rays. Treatment typically involves antibiotics and supportive care, such as oxygen therapy and mechanical ventilation, to manage symptoms and prevent complications.

Prevention of pneumonic pasteurellosis includes avoiding close contact with infected animals, wearing protective clothing and equipment when handling animals, and properly cleaning and disinfecting animal products and facilities. Vaccination of animals is also recommended to reduce the risk of transmission to humans.

The common types of RTIs include:

1. Common cold: A viral infection that affects the upper respiratory tract, causing symptoms such as runny nose, sneezing, coughing, and mild fever.
2. Influenza (flu): A viral infection that can affect both the upper and lower respiratory tract, causing symptoms such as fever, cough, sore throat, and body aches.
3. Bronchitis: An inflammation of the bronchial tubes, which can be caused by viruses or bacteria, resulting in symptoms such as coughing, wheezing, and shortness of breath.
4. Pneumonia: An infection of the lungs that can be caused by bacteria, viruses, or fungi, leading to symptoms such as fever, chills, coughing, and difficulty breathing.
5. Tonsillitis: An inflammation of the tonsils, which can be caused by bacteria or viruses, resulting in symptoms such as sore throat, difficulty swallowing, and bad breath.
6. Sinusitis: An inflammation of the sinuses, which can be caused by viruses, bacteria, or fungi, leading to symptoms such as headache, facial pain, and nasal congestion.
7. Laryngitis: An inflammation of the larynx (voice box), which can be caused by viruses or bacteria, resulting in symptoms such as hoarseness, loss of voice, and difficulty speaking.

RTIs can be diagnosed through physical examination, medical history, and diagnostic tests such as chest X-rays, blood tests, and nasal swab cultures. Treatment for RTIs depends on the underlying cause and may include antibiotics, antiviral medications, and supportive care to manage symptoms.

It's important to note that RTIs can be contagious and can spread through contact with an infected person or by touching contaminated surfaces. Therefore, it's essential to practice good hygiene, such as washing hands frequently, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick.

There are several types of pulmonary fibrosis, including:

1. Idiopathic pulmonary fibrosis (IPF): This is the most common and severe form of the disease, with no known cause or risk factors. It is characterized by a rapid decline in lung function and poor prognosis.
2. Connective tissue disease-associated pulmonary fibrosis: This type is associated with conditions such as rheumatoid arthritis, systemic lupus erythematosus, and scleroderma.
3. Drug-induced pulmonary fibrosis: Certain medications, such as amiodarone and nitrofurantoin, can cause lung damage and scarring.
4. Radiation-induced pulmonary fibrosis: Exposure to high doses of radiation, especially in childhood, can increase the risk of developing pulmonary fibrosis later in life.
5. Environmental exposures: Exposure to pollutants such as silica, asbestos, and coal dust can increase the risk of developing pulmonary fibrosis.

Symptoms of pulmonary fibrosis include shortness of breath, coughing, and fatigue. The disease can be diagnosed through a combination of imaging tests such as chest X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI), as well as lung biopsy.

Treatment options for pulmonary fibrosis are limited and vary depending on the underlying cause of the disease. Medications such as pirfenidone and nintedanib can help slow the progression of the disease, while lung transplantation may be an option for advanced cases.

Klebsiella Infections can occur in anyone, but certain groups of people are at higher risk, such as premature infants, people with weakened immune systems, and those with chronic medical conditions like diabetes, liver or kidney disease.

Symptoms of Klebsiella Infections include fever, chills, cough, difficulty breathing, painful urination, redness and swelling in the affected area, and in severe cases, sepsis and death.

Diagnosis of Klebsiella Infections is typically made through a combination of physical examination, medical history, and laboratory tests, such as blood cultures and urine cultures.

Treatment of Klebsiella Infections usually involves antibiotics, which can help clear the infection and prevent it from spreading. In severe cases, hospitalization may be necessary to provide appropriate care and monitoring.

Prevention of Klebsiella Infections includes good hand hygiene, proper cleaning and disinfection of equipment and surfaces, and avoiding close contact with individuals who have the infection. Vaccines are also available for certain types of Klebsiella Infections, such as pneumonia.

Complications of Klebsiella Infections can include pneumonia, urinary tract infections, bloodstream infections, and sepsis, which can lead to organ failure and death if left untreated.

Recovery from Klebsiella Infections usually occurs within a few days to a week after antibiotic treatment is started, but in severe cases, recovery may take longer and may require hospitalization and close monitoring.

In conclusion, Klebsiella Infections are a type of bacterial infection that can affect various parts of the body, and can be mild or severe. Prompt diagnosis and treatment with antibiotics are essential to prevent complications and ensure a successful recovery. Proper hygiene practices and vaccines are also important for preventing the spread of these infections.

Epidemiology of Haemophilus Infections:

* Incidence: Hib disease was once a major cause of childhood meningitis and sepsis, but the introduction of Hib vaccines in the 1980s has significantly reduced the incidence of invasive Hib disease. Non-invasive Hib disease, such as otitis media, is still common.
* Prevalence: Hib is the leading cause of bacterial meningitis in children under the age of 5 worldwide. In developed countries, the prevalence of invasive Hib disease has decreased significantly since the introduction of vaccines, but it remains a significant public health problem in developing countries.
* Risk factors: young age, poverty, lack of access to healthcare, and poor sanitation and hygiene are risk factors for Hib disease. Children under the age of 5, especially those under the age of 2, are at highest risk for invasive Hib disease.

Pathophysiology of Haemophilus Infections:

* Mechanisms of infection: H. influenzae can cause both respiratory and non-respiratory infections by colonizing the nasopharynx and other mucosal surfaces. The bacteria can then disseminate to other parts of the body, causing invasive disease.
* Immune response: the immune response to Hib infection involves both humoral and cell-mediated immunity. Antibodies play a crucial role in protecting against reinfection, while T cells and macrophages help to clear the bacteria from the body.

Clinical Presentation of Haemophilus Infections:

* Respiratory infections: H. influenzae can cause various respiratory tract infections, including bronchitis, pneumonia, and sinusitis. Symptoms may include fever, cough, sore throat, and difficulty breathing.
* Non-respiratory infections: Hib can cause a range of non-respiratory infections, including meningitis, epiglottitis, and septic arthritis. These infections can have more severe symptoms and may require prompt medical attention.

Diagnosis of Haemophilus Infections:

* Diagnostic tests: diagnosis of Hib disease is based on a combination of clinical findings, laboratory tests, and radiologic studies. Blood cultures, lumbar puncture, and chest x-rays may be used to confirm the presence of the bacteria and assess the extent of infection.
* Laboratory testing: identification of Hib is based on its distinctive gram stain appearance and biochemical characteristics. Polymerase chain reaction (PCR) and DNA sequencing are also used to confirm the diagnosis.

Treatment and Prevention of Haemophilus Infections:

* Antibiotics: Hib infections are treated with antibiotics, such as amoxicillin or ceftriaxone. The choice of antibiotic depends on the severity and location of the infection.
* Vaccination: the Hib vaccine is recommended for children under 5 years old to prevent Hib disease. The vaccine is given in a series of 3-4 doses, with the first dose given at 2 months of age.
* Good hygiene practices: good hygiene practices, such as frequent handwashing and proper cleaning and disinfection, can help prevent the spread of Hib bacteria.

Complications of Haemophilus Infections:

* Meningitis: Hib meningitis can have serious complications, including hearing loss, learning disabilities, and seizures.
* Permanent brain damage: Hib infections can cause permanent brain damage, including cognitive and behavioral impairments.
* Respiratory failure: severe Hib pneumonia can lead to respiratory failure, which may require mechanical ventilation.
* Death: Hib infections can be life-threatening, especially in young children and those with underlying medical conditions.

In conclusion, Haemophilus infections are a serious public health concern, particularly for young children and those with underlying medical conditions. Prevention through vaccination and good hygiene practices is essential to reduce the risk of infection. Early diagnosis and treatment are critical to prevent complications and improve outcomes.

Examples of OIs include:

1. Pneumocystis pneumonia (PCP): A type of pneumonia caused by the fungus Pneumocystis jirovecii, which is commonly found in the lungs of individuals with HIV/AIDS.
2. Cryptococcosis: A fungal infection caused by Cryptococcus neoformans, which can affect various parts of the body, including the lungs, central nervous system, and skin.
3. Aspergillosis: A fungal infection caused by Aspergillus fungi, which can affect various parts of the body, including the lungs, sinuses, and brain.
4. Histoplasmosis: A fungal infection caused by Histoplasma capsulatum, which is commonly found in the soil and can cause respiratory and digestive problems.
5. Candidiasis: A fungal infection caused by Candida albicans, which can affect various parts of the body, including the skin, mouth, throat, and vagina.
6. Toxoplasmosis: A parasitic infection caused by Toxoplasma gondii, which can affect various parts of the body, including the brain, eyes, and lymph nodes.
7. Tuberculosis (TB): A bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
8. Kaposi's sarcoma-associated herpesvirus (KSHV): A viral infection that can cause various types of cancer, including Kaposi's sarcoma, which is more common in individuals with compromised immunity.

The diagnosis and treatment of OIs depend on the specific type of infection and its severity. Treatment may involve antibiotics, antifungals, or other medications, as well as supportive care to manage symptoms and prevent complications. It is important for individuals with HIV/AIDS to receive prompt and appropriate treatment for OIs to help prevent the progression of their disease and improve their quality of life.

Examples of acute diseases include:

1. Common cold and flu
2. Pneumonia and bronchitis
3. Appendicitis and other abdominal emergencies
4. Heart attacks and strokes
5. Asthma attacks and allergic reactions
6. Skin infections and cellulitis
7. Urinary tract infections
8. Sinusitis and meningitis
9. Gastroenteritis and food poisoning
10. Sprains, strains, and fractures.

Acute diseases can be treated effectively with antibiotics, medications, or other therapies. However, if left untreated, they can lead to chronic conditions or complications that may require long-term care. Therefore, it is important to seek medical attention promptly if symptoms persist or worsen over time.

Some common types of lung diseases include:

1. Asthma: A chronic condition characterized by inflammation and narrowing of the airways, leading to wheezing, coughing, and shortness of breath.
2. Chronic Obstructive Pulmonary Disease (COPD): A progressive condition that causes chronic inflammation and damage to the airways and lungs, making it difficult to breathe.
3. Pneumonia: An infection of the lungs that can be caused by bacteria, viruses, or fungi, leading to fever, chills, coughing, and difficulty breathing.
4. Bronchiectasis: A condition where the airways are damaged and widened, leading to chronic infections and inflammation.
5. Pulmonary Fibrosis: A condition where the lungs become scarred and stiff, making it difficult to breathe.
6. Lung Cancer: A malignant tumor that develops in the lungs, often caused by smoking or exposure to carcinogens.
7. Cystic Fibrosis: A genetic disorder that affects the respiratory and digestive systems, leading to chronic infections and inflammation in the lungs.
8. Tuberculosis (TB): An infectious disease caused by Mycobacterium Tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
9. Pulmonary Embolism: A blockage in one of the arteries in the lungs, often caused by a blood clot that has traveled from another part of the body.
10. Sarcoidosis: An inflammatory disease that affects various organs in the body, including the lungs, leading to the formation of granulomas and scarring.

These are just a few examples of conditions that can affect the lungs and respiratory system. It's important to note that many of these conditions can be treated with medication, therapy, or surgery, but early detection is key to successful treatment outcomes.

Synonyms: Pneumovirus disease; Respiratory syncytial virus infection; Human metapneumovirus infection.

Types:

1. Respiratory syncytial virus (RSV) infection: The most common cause of lower respiratory tract infections in infants and young children worldwide. It can also affect older adults and people with weakened immune systems.
2. Human metapneumovirus (HMPV) infection: Causes milder symptoms than RSV but can lead to more severe illness in certain populations, such as the elderly and those with underlying health conditions.

Symptoms:

1. Coughing
2. Sneezing
3. Runny nose
4. Fever
5. Wheezing
6. Shortness of breath or difficulty breathing
7. Pneumonia (in severe cases)

Diagnosis:

1. Physical examination
2. Medical history
3. Chest X-ray or CT scan to rule out pneumonia
4. Nasal swab or throat swab for viral testing

Treatment and Prevention:

1. Antiviral medications may be prescribed for severe cases or those with underlying health conditions.
2. Over-the-counter medications, such as acetaminophen or ibuprofen, can help relieve symptoms.
3. Rest and hydration are essential to recover from pneumovirus infections.
4. Good hygiene practices, such as frequent handwashing, can help prevent the spread of the virus.
5. Vaccines are available for RSV and HMPV, primarily given to high-risk populations, such as infants and young children.

Complications:

1. Pneumonia
2. Bronchiolitis
3. Respiratory failure
4. Meningitis or encephalitis (rare)
5. Complications from preexisting conditions, such as heart disease or diabetes

It is essential to seek medical attention if symptoms worsen or if there are signs of complications, such as difficulty breathing, confusion, or chest pain. Early diagnosis and treatment can help prevent severe complications and improve the prognosis for pneumovirus infections.

The Pneumocystis jirovecii fungus is a dimorphic fungus which means it can exist in two forms:
- A trophozoite form that multiplies within host cells and tissues
- A fungal form that grows outside of the host's body, this form is not infectious.

The infection occurs when the fungus enters the lungs through the breathing in airborne spores, from there it multiplies in the alveoli (small air sacs) and causes inflammation and damage to the lung tissue.
Symptoms of PCP can vary depending on the severity of the infection but they usually include:
- Cough
- Fever
- Shortness of breath
- Chest pain
- Dry cough (which may produce small amounts of mucus)
The symptoms can progress rapidly and if left untreated PCP can lead to respiratory failure, sepsis and death.
There are several diagnostic tests that can be used to confirm the presence of a Pneumocystis infection such as:
- Chest radiographs or computed tomography (CT) scans which can show signs of inflammation or consolidation in the lungs, these tests may also reveal pleural effusion (fluid accumulation around the lungs).
- Blood tests such as complete blood count (CBC) and polymerase chain reaction (PCR) to detect the presence of fungal DNA in the blood.

Treatment of PCP involves a combination of antifungal medications and supportive care, the most commonly used antifungal medication is Trimethoprim-sulfamethoxazole. In severe cases of PCP hospitalization may be required to provide oxygen therapy and mechanical ventilation. Prevention is key for those at risk for developing PCP including HIV/AIDS patients, those with compromised immune systems and those undergoing immunosuppressive therapy.

Symptoms of lung abscess may include:

* Coughing up bloody or rust-colored sputum
* Chest pain that worsens with deep breathing or coughing
* Fever and chills
* Shortness of breath
* Fatigue

If you suspect that you have lung abscess, it is important to seek medical attention as soon as possible. A healthcare professional will perform a physical examination and order diagnostic tests, such as chest X-rays or CT scans, to confirm the diagnosis. Treatment typically involves antibiotics to eliminate the infection and drainage of the abscess. In severe cases, surgery may be necessary to remove the abscess.

Preventive measures for lung abscess include:

* Practicing good hygiene, such as washing your hands frequently and avoiding close contact with people who are sick
* Getting vaccinated against pneumococcal disease, which can help prevent Streptococcus pneumoniae infections
* Avoiding smoking and exposure to secondhand smoke, which can increase the risk of lung infections

It is important to note that lung abscess can be a serious condition and can lead to complications such as respiratory failure or sepsis. If you suspect that you have lung abscess, it is important to seek medical attention as soon as possible to receive proper treatment and prevent any further complications.

Pasteurella infections are more common in people who work closely with animals, such as veterinarians, farm workers, and pet owners. The bacteria can enter the body through open wounds, cuts, or abrasions, and it can cause a variety of illnesses, including:

1. Pasteurellosis: A respiratory infection caused by Pasteurella multocida, which is common in dogs and cats. It can be transmitted to humans through close contact with infected animals.
2. Pneumonia: A type of lung infection that can be caused by Pasteurella multocida, especially in people with weakened immune systems or pre-existing respiratory conditions.
3. Sinusitis: An infection of the sinuses, which are air-filled cavities in the skull, can be caused by Pasteurella multocida.
4. Cellulitis: A bacterial infection of the skin and underlying tissue that can be caused by Pasteurella multocida.
5. Endocarditis: An infection of the inner lining of the heart, which is rare but can be caused by Pasteurella multocida.

The symptoms of Pasteurella infections can vary depending on the type of infection and the severity of the illness. Common symptoms include fever, cough, difficulty breathing, chills, headache, and fatigue. In severe cases, Pasteurella infections can lead to life-threatening complications such as sepsis or meningitis.

Diagnosis of Pasteurella infections typically involves a combination of physical examination, medical history, and laboratory tests, including blood cultures, chest X-rays, and CT scans. Treatment usually involves antibiotics to eradicate the bacteria, as well as supportive care to manage symptoms and prevent complications.

Prevention of Pasteurella infections primarily involves avoiding contact with animals that may carry the bacteria, as well as good hygiene practices such as handwashing and covering wounds. In some cases, antibiotics may be prescribed to prevent infection in high-risk individuals, such as those with weakened immune systems or pre-existing respiratory conditions.

Overall, while Pasteurella infections are rare, they can be serious and potentially life-threatening. It is important to seek medical attention promptly if symptoms persist or worsen over time, especially in high-risk individuals.

Here are some key points to define sepsis:

1. Inflammatory response: Sepsis is characterized by an excessive and uncontrolled inflammatory response to an infection. This can lead to tissue damage and organ dysfunction.
2. Systemic symptoms: Patients with sepsis often have systemic symptoms such as fever, chills, rapid heart rate, and confusion. They may also experience nausea, vomiting, and diarrhea.
3. Organ dysfunction: Sepsis can cause dysfunction in multiple organs, including the lungs, kidneys, liver, and heart. This can lead to organ failure and death if not treated promptly.
4. Infection source: Sepsis is usually caused by a bacterial infection, but it can also be caused by fungal or viral infections. The infection can be localized or widespread, and it can affect different parts of the body.
5. Severe sepsis: Severe sepsis is a more severe form of sepsis that is characterized by severe organ dysfunction and a higher risk of death. Patients with severe sepsis may require intensive care unit (ICU) admission and mechanical ventilation.
6. Septic shock: Septic shock is a life-threatening condition that occurs when there is severe circulatory dysfunction due to sepsis. It is characterized by hypotension, vasopressor use, and organ failure.

Early recognition and treatment of sepsis are critical to preventing serious complications and improving outcomes. The Sepsis-3 definition is widely used in clinical practice to diagnose sepsis and severe sepsis.

There are several types of respiratory insufficiency, including:

1. Hypoxemic respiratory failure: This occurs when the lungs do not take in enough oxygen, resulting in low levels of oxygen in the bloodstream.
2. Hypercapnic respiratory failure: This occurs when the lungs are unable to remove enough carbon dioxide from the bloodstream, leading to high levels of carbon dioxide in the bloodstream.
3. Mixed respiratory failure: This occurs when both hypoxemic and hypercapnic respiratory failure occur simultaneously.

Treatment for respiratory insufficiency depends on the underlying cause and may include medications, oxygen therapy, mechanical ventilation, and other supportive care measures. In severe cases, lung transplantation may be necessary. It is important to seek medical attention if symptoms of respiratory insufficiency are present, as early intervention can improve outcomes and prevent complications.

The term "idiopathic" means that the cause of the disease is unknown, and "pulmonary fibrosis" refers to the scarring and thickening of the lung tissue that occurs in the disease. The scarring can lead to loss of lung function, shortness of breath, and coughing, making it difficult for patients to perform everyday activities.

IPF typically affects older adults, and men are more likely to be affected than women. The symptoms of IPF can vary from person to person but may include:

* Shortness of breath
* Coughing
* Fatigue
* Loss of appetite
* Weight loss
* Chest tightness or pain

There is no cure for IPF, and treatment options are limited. However, there are medications available that can help manage symptoms and slow the progression of the disease. It is important for patients with suspected IPF to seek medical attention as soon as possible to receive an accurate diagnosis and appropriate treatment.

A type of pneumonia caused by the bacterium Rickettsia prowazekii. It is transmitted through the bite of an infected mite, usually found in the respiratory tract of birds and other small animals. This type of pneumonia is most commonly seen in people who have been exposed to these biting insects while camping, hiking, or engaging in other outdoor activities.

Symptoms include fever, chills, cough, shortness of breath, and muscle pain. Diagnosis is based on a combination of physical examination, laboratory tests, and medical history. Treatment typically involves antibiotics and supportive care, such as oxygen therapy and respiratory assistance.

Prevention includes avoiding contact with infected mites, wearing protective clothing when outdoors, and using insect repellents. Early detection and prompt treatment are important to prevent serious complications and improve outcomes for patients with rickettsial pneumonia.

Some common causes of confusion in the medical field include:

1. Medication side effects: Certain medications can cause confusion as a side effect, particularly those that affect the central nervous system, such as sedatives, anti-anxiety drugs, and painkillers.
2. Delirium: A sudden and severe confusional state that can be caused by various factors, such as infections, surgery, or alcohol or drug withdrawal.
3. Dementia: A progressive decline in cognitive function that can cause confusion, memory loss, and difficulty with communication and daily activities. Alzheimer's disease is the most common cause of dementia.
4. Traumatic brain injury: A head injury that can cause confusion, memory loss, and other cognitive difficulties.
5. Stroke: A loss of blood flow to the brain that can cause confusion, weakness, and difficulty with speech and mobility.
6. Infections: Certain infections, such as urinary tract infections or sepsis, can cause confusion and disorientation.
7. Sleep disorders: Sleep disturbances, such as insomnia or sleep apnea, can lead to confusion and other cognitive difficulties.
8. Chronic conditions: Certain chronic conditions, such as diabetes, hypertension, or hypothyroidism, can cause confusion if left untreated or poorly managed.
9. Nutritional deficiencies: Deficiencies in certain nutrients, such as vitamin B12 or thiamine, can cause confusion and other cognitive difficulties.
10. Substance abuse: Withdrawal from drugs or alcohol can cause confusion, agitation, and other cognitive difficulties.

In the medical field, confusion is often evaluated through a series of questions and physical examinations to determine its underlying cause. Treatment may involve addressing any underlying conditions, managing symptoms, and providing supportive care to help improve cognitive function. In some cases, medication or other interventions may be necessary to manage symptoms and improve quality of life.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

There are several types of Mycoplasma bacteria that can cause infection in humans, including:

1. Mycoplasma pneumoniae, which is the most common cause of atypical pneumonia and can also cause sinus infections, bronchitis, and other respiratory infections.
2. Mycoplasma genitalium, which can cause pelvic inflammatory disease, epididymitis, and urethritis.
3. Mycoplasma hominis, which is a common inhabitant of the human respiratory tract and can cause infections such as pneumonia and bronchitis.
4. Mycoplasma fermentans, which is associated with respiratory infections and has been linked to conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Mycoplasma infections are typically diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood cultures and PCR (polymerase chain reaction) tests. Treatment for Mycoplasma infections usually involves antibiotics, but the type and duration of treatment may vary depending on the severity and location of the infection.

Prevention measures for Mycoplasma infections include good hygiene practices such as frequent handwashing, avoiding close contact with people who are sick, and covering the mouth and nose when coughing or sneezing. Vaccines are also available for some types of Mycoplasma bacteria, such as the M. pneumoniae vaccine, which is recommended for certain high-risk groups.

Overall, Mycoplasma infections can be serious and potentially life-threatening, especially in certain populations such as young children, older adults, and people with weakened immune systems. If you suspect that you or someone you know may have a Mycoplasma infection, it is important to seek medical attention right away.

Types of fungal lung diseases include:

1. Aspergillosis: This is an infection caused by the fungus Aspergillus, which is commonly found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive drugs.
2. Cryptococcosis: This is an infection caused by the fungus Cryptococcus neoformans, which is found in soil and decaying wood. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
3. Histoplasmosis: This is an infection caused by the fungus Histoplasma capsulatum, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
4. Pneumocystis pneumonia (PCP): This is an infection caused by the fungus Pneumocystis jirovecii, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
5. Sporotrichosis: This is an infection caused by the fungus Sporothrix schenckii, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.

Symptoms of fungal lung diseases can include:

* Cough
* Fever
* Chest pain
* Shortness of breath
* Fatigue

Diagnosis of fungal lung diseases is typically made through a combination of physical examination, medical history, and laboratory tests such as chest X-rays, CT scans, and fungal cultures. Treatment usually involves antifungal medications and may also include supportive care to manage symptoms.

Prevention of fungal lung diseases includes:

1. Avoiding exposure to fungal spores by wearing protective clothing and gear when working with soil or decaying organic matter.
2. Maintaining good indoor air quality by using ventilation systems and reducing humidity.
3. Reducing the risk of infection by avoiding close contact with people who are at high risk of developing fungal lung diseases, such as those with weakened immune systems.
4. Avoiding smoking and other tobacco products, which can increase the risk of developing fungal lung diseases.
5. Managing underlying medical conditions, such as HIV/AIDS or taking immunosuppressive drugs, to reduce the risk of developing fungal lung diseases.

Some common types of deglutition disorders include:

1. Dysphagia: This is a condition where individuals have difficulty swallowing food and liquids due to weakened or impaired swallowing muscles.
2. Aphasia: This is a condition where individuals have difficulty speaking and understanding language, which can also affect their ability to swallow.
3. Apraxia of speech: This is a condition where individuals have difficulty coordinating the muscles of the mouth and tongue to produce speech, which can also affect their ability to swallow.
4. Aspiration: This is a condition where food or liquids enter the trachea instead of the esophagus, which can cause respiratory problems and other complications.
5. Dystonia: This is a condition where individuals experience involuntary muscle contractions that can affect swallowing and other movements.

Deglutition disorders can be diagnosed through a variety of tests, including videofluoroscopy, fiber-optic endoscopic evaluation of swallowing (FEES), and instrumental assessment of swallowing physiology. Treatment options for deglutition disorders depend on the underlying cause and severity of the condition, and may include speech therapy, medications, surgery, or a combination of these.

In conclusion, deglutition disorders can significantly impact an individual's quality of life, making it important to seek medical attention if swallowing difficulties are experienced. With proper diagnosis and treatment, many individuals with deglutition disorders can improve their swallowing abilities and regain their independence in eating and drinking.

Symptoms include depression, loss of appetite, coughing, nasal discharge, fever, and difficulty breathing. Treatment includes antibiotics and supportive care. The prognosis is generally good if treatment is initiated early, but the condition can be severe and sometimes fatal if left untreated.

Prevention is possible through vaccination against certain bacteria and viruses that cause the disease. Good husbandry practices such as providing clean water and adequate ventilation in barns can also help reduce the risk of infection.

Gram-negative bacterial infections can be difficult to treat because these bacteria are resistant to many antibiotics. In addition, some gram-negative bacteria produce enzymes called beta-lactamases, which break down the penicillin ring of many antibiotics, making them ineffective against the infection.

Some common types of gram-negative bacterial infections include:

* Pneumonia
* Urinary tract infections (UTIs)
* Bloodstream infections (sepsis)
* Meningitis
* Skin and soft tissue infections
* Respiratory infections, such as bronchitis and sinusitis

Examples of gram-negative bacteria that can cause infection include:

* Escherichia coli (E. coli)
* Klebsiella pneumoniae
* Pseudomonas aeruginosa
* Acinetobacter baumannii
* Proteus mirabilis

Gram-negative bacterial infections can be diagnosed through a variety of tests, including blood cultures, urine cultures, and tissue samples. Treatment typically involves the use of broad-spectrum antibiotics, such as carbapenems or cephalosporins, which are effective against many types of gram-negative bacteria. In some cases, the infection may require hospitalization and intensive care to manage complications such as sepsis or organ failure.

Prevention of gram-negative bacterial infections includes good hand hygiene, proper use of personal protective equipment (PPE), and appropriate use of antibiotics. In healthcare settings, infection control measures such as sterilization and disinfection of equipment, and isolation precautions for patients with known gram-negative bacterial infections can help prevent the spread of these infections.

Overall, gram-negative bacterial infections are a significant public health concern, and proper diagnosis and treatment are essential to prevent complications and reduce the risk of transmission.

* Parainfluenza: This is a group of viruses that cause upper respiratory tract infections, such as colds and sore throats.
* Mumps: This is a viral infection that causes swelling of the salivary glands, particularly in children.
* Measles: This is a highly contagious viral infection that causes fever, rash, and respiratory symptoms.
* Rubella (German measles): This is a viral infection that causes fever, rash, and mild respiratory symptoms.

Symptoms of paramyxovirus infections can vary depending on the specific virus causing the infection. However, common symptoms include:

* Fever
* Cough
* Runny nose
* Sore throat
* Headache
* Body aches
* Fatigue
* Swollen glands
* Rash (in the case of measles and rubella)

Diagnosis of paramyxovirus infections is typically made based on symptoms, physical examination, and laboratory tests such as PCR (polymerase chain reaction) or ELISA (enzyme-linked immunosorbent assay). Treatment is primarily focused on relieving symptoms and supporting the body's immune system. Antiviral medications may be prescribed in some cases, such as for severe measles infections.

Prevention of paramyxovirus infections includes vaccination against measles, mumps, and rubella (MMR vaccine), good hygiene practices such as handwashing and avoiding close contact with people who are sick, and avoiding sharing food and drinks.

Overall, paramyxovirus infections can be serious and potentially life-threatening, particularly in young children and immunocompromised individuals. However, with proper diagnosis, treatment, and prevention measures, the risk of complications and death can be significantly reduced.

Terms related to Bronchiolitis:

* Acute bronchiolitis: This is a sudden and severe form of bronchiolitis that typically lasts for a few days.
* Chronic bronchiolitis: This is a long-term condition characterized by persistent inflammation and narrowing of the airways.
* Asthmatic bronchiolitis: This is a type of bronchiolitis that is associated with asthma.

Synonyms for Bronchiolitis:

* Bronchitis
* Pneumonia
* Respiratory syncytial virus (RSV) infection

Antonyms for Bronchiolitis:

* None

Hypernyms for Bronchiolitis:

* Respiratory disease
* Infectious disease

Hypersonyms for Bronchiolitis:

* Acute bronchiolitis
* Chronic bronchiolitis
* Asthmatic bronchiolitis

Collocations for Bronchiolitis:

* Viral bronchiolitis
* Bacterial bronchiolitis
* Allergic bronchiolitis

Idiomatic expressions related to Bronchiolitis:

* "Bronchiolitis attack"
* "Bronchiolitis episode"
* "Bronchiolitis flare-up"

Phrases that include Bronchiolitis:

* "Bronchiolitis diagnosis"
* "Bronchiolitis treatment"
* "Bronchiolitis management"

Other words that are related to Bronchiolitis but not included in the list above:

* Mucus
* Cough
* Wheezing
* Shortness of breath
* Chest tightness
* Fever
* Runny nose

Note: Some of these words may have multiple meanings or be used in different contexts, but they are all related to Bronchiolitis in some way.

1. Tuberculosis: Actinomycetales bacteria can cause tuberculosis, which is a chronic bacterial infection that primarily affects the lungs but can also affect other parts of the body.
2. Leprosy: Actinomycetales bacteria can cause leprosy, which is a chronic infectious disease that affects the skin, nerves, and mucous membranes.
3. Lung abscess: Actinomycetales bacteria can cause lung abscess, which is a collection of pus in the lungs that can be caused by bacterial infections.
4. Skin infections: Actinomycetales bacteria can cause skin infections, such as furuncles and carbuncles, which are boils that can be caused by bacterial infections.
5. Bone and joint infections: Actinomycetales bacteria can cause bone and joint infections, such as osteomyelitis and septic arthritis, which are infections of the bones and joints.
6. Endocarditis: Actinomycetales bacteria can cause endocarditis, which is an infection of the heart valves.
7. Meningitis: Actinomycetales bacteria can cause meningitis, which is an inflammation of the membranes that cover the brain and spinal cord.
8. Osteomyelitis: Actinomycetales bacteria can cause osteomyelitis, which is an infection of the bones.
9. Septic arthritis: Actinomycetales bacteria can cause septic arthritis, which is an infection of the joints.
10. Soft tissue infections: Actinomycetales bacteria can cause soft tissue infections, such as abscesses and cellulitis, which are infections of the skin and underlying tissues.

The symptoms of Actinomycetales infections vary depending on the location and severity of the infection, but may include fever, chills, joint pain, swelling, redness, and warmth over the affected area. In severe cases, Actinomycetales infections can lead to life-threatening complications such as sepsis and organ failure.

Actinomycetales bacteria are typically resistant to antibiotics, making treatment challenging. Surgical intervention is often necessary to remove infected tissue or repair damaged structures. In some cases, combination therapy with antibiotics and surgery may be required to effectively treat Actinomycetales infections.

Preventive measures for Actinomycetales infections include proper hand hygiene, sterilization of medical equipment, and avoiding close contact with individuals who are at risk of developing an Actinomycetales infection. Early detection and treatment of Actinomycetales infections are crucial to prevent serious complications and improve outcomes for patients.

The symptoms of tracheitis may include:

* Fever
* Cough
* Difficulty breathing
* Chest pain
* Wheezing
* Shortness of breath

Tracheitis can be caused by a variety of factors, including:

* Bacterial or viral infections
* Allergies
* Irritants such as smoke or pollution
* Inflammatory conditions such as asthma or chronic obstructive pulmonary disease (COPD)

Tracheitis is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as X-rays or endoscopy. Treatment for tracheitis may include antibiotics, anti-inflammatory medications, and supportive care to help manage symptoms such as coughing and difficulty breathing. In severe cases, hospitalization may be necessary to provide oxygen therapy and other forms of supportive care.

Complications of tracheitis can include:

* Respiratory failure
* Pneumonia
* Bronchiectasis (a condition in which the airways become damaged and widened)
* Chronic cough

Prevention of tracheitis may include:

* Practicing good hygiene, such as washing hands regularly and avoiding close contact with people who are sick
* Avoiding exposure to irritants such as smoke or pollution
* Managing underlying conditions such as allergies or COPD
* Getting vaccinated against respiratory infections such as influenza and pneumococcus.

Types of Adenoviridae Infections:

1. Respiratory adenovirus infection (bronchiolitis, pneumonia)
2. Gastroenteric adenovirus infection (gastroenteritis)
3. Eye adenovirus infection (conjunctivitis)
4. Skin adenovirus infection (keratoconjunctivitis)
5. Intestinal adenovirus infection (diarrhea, vomiting)
6. Adenovirus-associated hemorrhagic cystitis
7. Adenovirus-associated hypertrophic cardiomyopathy
8. Adenovirus-associated myocarditis

Symptoms of Adenoviridae Infections:

1. Respiratory symptoms (cough, fever, difficulty breathing)
2. Gastrointestinal symptoms (diarrhea, vomiting, abdominal pain)
3. Eye symptoms (redness, discharge, sensitivity to light)
4. Skin symptoms (rash, blisters, skin erosion)
5. Intestinal symptoms (abdominal cramps, fever, chills)
6. Cardiovascular symptoms (hypertension, tachycardia, myocarditis)

Diagnosis of Adenoviridae Infections:

1. Physical examination and medical history
2. Laboratory tests (rapid antigen detection, PCR, electron microscopy)
3. Imaging studies (chest X-ray, CT scan, MRI)
4. Biopsy (tissue or organ biopsy)

Treatment of Adenoviridae Infections:

1. Supportive care (fluids, oxygen therapy, pain management)
2. Antiviral medications (ribavirin, cidofovir)
3. Immune modulators (immunoglobulins, corticosteroids)
4. Surgical intervention (in severe cases of adenovirus-associated disease)

Prevention of Adenoviridae Infections:

1. Good hygiene practices (handwashing, surface cleaning)
2. Avoiding close contact with individuals who are infected
3. Properly storing and preparing food
4. Avoiding sharing of personal items (utensils, drinking glasses, towels)
5. Immunization (vaccination against adenovirus)

Incubation Period:
The incubation period for adenoviruses is typically between 3-7 days, but it can range from 1-2 weeks in some cases.

Contagious Period:
Adenoviruses are highly contagious and can be transmitted before symptoms appear and during the entire course of illness. The virus can be shed for several weeks after infection.

Risk Factors:
Individuals with weakened immune systems (children, elderly, those with chronic illnesses) are at a higher risk of developing severe adenovirus infections. Additionally, those who live in crowded or unsanitary conditions and those who engage in behaviors that compromise their immune system (smoking, excessive alcohol consumption) are also at a higher risk.

Complications:
Adenovirus infections can lead to a variety of complications, including pneumonia, meningitis, encephalitis, and other respiratory, gastrointestinal, and eye infections. In severe cases, adenovirus infections can be fatal.

Recovery Time:
The recovery time for adenovirus infections varies depending on the severity of the infection and the individual's overall health. Mild cases of adenovirus may resolve within a few days to a week, while more severe cases may take several weeks to recover from. In some cases, hospitalization may be necessary for individuals with severe infections or those who experience complications.

Contraception:
There is no specific contraceptive measure that can prevent adenovirus infections. However, practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission.

Pregnancy:
Adenovirus infections during pregnancy are rare but can be severe. Pregnant women who develop adenovirus infections may experience complications such as preterm labor and low birth weight. It is essential for pregnant women to seek medical attention immediately if they suspect they have an adenovirus infection.

Diagnosis:
Adenovirus infections can be diagnosed through a variety of tests, including polymerase chain reaction (PCR), electron microscopy, and culture. A healthcare provider will typically perform a physical examination and take a medical history to determine the likelihood of an adenovirus infection.

Treatment:
There is no specific treatment for adenovirus infections, but symptoms can be managed with supportive care such as hydration, rest, and over-the-counter pain relievers. Antiviral medications may be prescribed in severe cases or for individuals with compromised immune systems.

Prevention:
Preventing the spread of adenovirus is essential, especially in high-risk populations such as young children and those with weakened immune systems. Practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission. Vaccines are also available for some types of adenovirus.

Prognosis:
The prognosis for adenovirus infections is generally good, especially for mild cases. However, severe cases can lead to complications such as pneumonia, meningitis, and encephalitis, which can be life-threatening. In some cases, long-term health problems may persist after recovery from an adenovirus infection.

Complications:
Adenovirus infections can lead to various complications, including:

1. Pneumonia: Adenovirus can cause pneumonia, which is an inflammation of the lungs that can lead to fever, chest pain, and difficulty breathing.
2. Meningitis: Adenovirus can cause meningitis, which is an inflammation of the membranes surrounding the brain and spinal cord. Symptoms include headache, stiff neck, and sensitivity to light.
3. Encephalitis: Adenovirus can cause encephalitis, which is an inflammation of the brain that can lead to confusion, seizures, and coma.
4. Gastrointestinal symptoms: Adenovirus can cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain.
5. Long-term health problems: In some cases, adenovirus infections can lead to long-term health problems such as asthma, allergies, and autoimmune disorders.

Some common types of Acinetobacter infections include:

1. Pneumonia: This is an infection of the lungs that can cause fever, cough, chest pain, and difficulty breathing.
2. Urinary tract infections (UTIs): These are infections of the bladder, kidneys, or ureters that can cause symptoms such as burning during urination, frequent urination, and abdominal pain.
3. Bloodstream infections (sepsis): This is a serious and potentially life-threatening condition that occurs when bacteria enter the bloodstream and cause widespread inflammation. Symptoms can include fever, chills, rapid heart rate, and shortness of breath.
4. Skin and soft tissue infections: These are infections of the skin and underlying tissues that can cause redness, swelling, warmth, and pain.
5. Bacteremia: This is a condition in which bacteria enter the bloodstream and cause an infection.
6. Endocarditis: This is an infection of the heart valves, which can cause symptoms such as fever, fatigue, and shortness of breath.

Acinetobacter infections are often caused by the bacteria entering the body through a wound or surgical incision. They can also be spread through contact with contaminated surfaces or equipment in healthcare settings.

Treatment of Acinetobacter infections typically involves the use of antibiotics, which may be administered intravenously or orally. In some cases, surgical intervention may be necessary to remove infected tissue or repair damaged organs.

Prevention of Acinetobacter infections is important for reducing the risk of these infections occurring in healthcare settings. This can include proper hand hygiene, use of personal protective equipment (PPE), and effective cleaning and disinfection of surfaces and equipment.

Overall, Acinetobacter infections are a significant concern in healthcare settings, and prompt recognition and treatment are critical for preventing serious complications and improving patient outcomes.

Some common types of lung diseases, parasitic include:

1. Aspergillosis: This is a fungal infection that can affect the lungs and other parts of the body. It is caused by the Aspergillus fungus and can lead to chronic inflammation and scarring in the lungs.
2. Pneumocystis pneumonia (PCP): This is a type of pneumonia that is caused by the Pneumocystis jirovecii fungus and is more common in people with weakened immune systems, such as those with HIV/AIDS or cancer.
3. Cryptococcosis: This is a fungal infection that can affect the lungs and central nervous system. It is caused by the Cryptococcus neoformans fungus and can lead to chronic inflammation and scarring in the lungs.
4. Histoplasmosis: This is a fungal infection that can affect the lungs and other parts of the body. It is caused by the Histoplasma capsulatum fungus and can lead to chronic inflammation and scarring in the lungs.
5. Chagas disease: This is a parasitic infection that is caused by the Trypanosoma cruzi parasite and can affect the heart and lungs, among other organs. It is more common in Latin America and can lead to chronic inflammation and scarring in the lungs.
6. Leishmaniasis: This is a parasitic infection that can affect various parts of the body, including the lungs. It is caused by the Leishmania parasite and can lead to chronic inflammation and scarring in the lungs.
7. Strongyloidiasis: This is a parasitic infection that is caused by the Strongyloides stercoralis parasite and can affect the lungs and other parts of the body. It can lead to chronic inflammation and scarring in the lungs.
8. Schistosomiasis: This is a parasitic infection that is caused by the Schistosoma parasite and can affect various parts of the body, including the lungs. It can lead to chronic inflammation and scarring in the lungs.
9. Lymphatic filariasis: This is a parasitic infection that is caused by the Wuchereria bancrofti or Brugia malayi parasites and can affect the lymph nodes and other parts of the body, including the lungs. It can lead to chronic inflammation and scarring in the lungs.
10. Tuberculosis: This is a bacterial infection that primarily affects the lungs and can lead to chronic inflammation and scarring in the lungs. It is caused by Mycobacterium tuberculosis and can be spread through the air when an infected person coughs or sneezes.

It is important to note that these conditions are not mutually exclusive, and individuals may have more than one condition affecting their lungs at the same time. It is also important to note that other factors such as smoking, exposure to environmental pollutants, and underlying medical conditions can increase the risk of developing chronic lung disease.

A healthcare professional should be consulted for an accurate diagnosis and appropriate treatment of any suspected lung conditions.

Orthomyxoviridae infections are a group of viral infections caused by the Orthomyxoviridae family of viruses, which includes influenza A and B viruses, as well as other related viruses. These infections can affect both humans and animals and can cause a range of symptoms, from mild to severe.

The most common type of Orthomyxoviridae infection is seasonal influenza, which occurs when the virus is transmitted from person to person through the air or by contact with infected surfaces. Other types of Orthomyxoviridae infections include:

1. Pandemic influenza: This occurs when a new strain of the virus emerges and spreads quickly around the world, causing widespread illness and death. Examples of pandemic influenza include the Spanish flu of 1918 and the Asian flu of 1957.
2. Avian influenza: This occurs when birds are infected with the virus and can be transmitted to humans through close contact with infected birds or their droppings.
3. Swine influenza: This occurs when pigs are infected with the virus and can be transmitted to humans through close contact with infected pigs or their droppings.
4. H5N1 and H7N9: These are two specific types of bird flu viruses that have caused serious outbreaks in humans in recent years.

Symptoms of Orthomyxoviridae infections can include fever, cough, sore throat, runny nose, muscle aches, and fatigue. In severe cases, these infections can lead to pneumonia, bronchitis, and other respiratory complications, as well as hospitalization and even death.

Diagnosis of Orthomyxoviridae infections is typically made through a combination of physical examination, medical history, and laboratory tests, such as PCR (polymerase chain reaction) or viral culture. Treatment is generally focused on relieving symptoms and supporting the immune system, with antiviral medications may be used in severe cases.

Prevention of Orthomyxoviridae infections can include avoiding close contact with infected birds or pigs, wearing protective clothing and gear when handling animals, and practicing good hygiene such as washing hands frequently. Vaccines are also available for some species of birds and pigs to protect against these viruses.

Overall, Orthomyxoviridae is a family of viruses that can cause serious illness in humans and other animals, and it's important to take precautions to prevent exposure and spread of these viruses.

Acute bronchitis is a short-term infection that is usually caused by a virus or bacteria, and can be treated with antibiotics and supportive care such as rest, hydration, and over-the-counter pain relievers. Chronic bronchitis, on the other hand, is a long-term condition that is often associated with smoking and can lead to chronic obstructive pulmonary disease (COPD).

Bronchitis can cause a range of symptoms including:

* Persistent cough, which may be dry or produce mucus
* Chest tightness or discomfort
* Shortness of breath or wheezing
* Fatigue and fever
* Headache and body aches

The diagnosis of bronchitis is usually made based on a physical examination, medical history, and results of diagnostic tests such as chest X-rays and pulmonary function tests. Treatment for bronchitis typically focuses on relieving symptoms and managing the underlying cause, such as a bacterial infection or smoking cessation.

Bronchitis can be caused by a variety of factors, including:

* Viral infections, such as the common cold or flu
* Bacterial infections, such as pneumonia
* Smoking and exposure to environmental pollutants
* Asthma and other allergic conditions
* Chronic lung diseases, such as COPD

Preventive measures for bronchitis include:

* Quitting smoking and avoiding exposure to secondhand smoke
* Getting vaccinated against flu and pneumonia
* Practicing good hygiene, such as washing hands frequently
* Avoiding exposure to environmental pollutants
* Managing underlying conditions such as asthma and allergies.

There are different types of fever, including:

1. Pyrexia: This is the medical term for fever. It is used to describe a body temperature that is above normal, usually above 38°C (100.4°F).
2. Hyperthermia: This is a more severe form of fever, where the body temperature rises significantly above normal levels.
3. Febrile seizure: This is a seizure that occurs in children who have a high fever.
4. Remittent fever: This is a type of fever that comes and goes over a period of time.
5. Intermittent fever: This is a type of fever that recurs at regular intervals.
6. Chronic fever: This is a type of fever that persists for an extended period of time, often more than 3 weeks.

The symptoms of fever can vary depending on the underlying cause, but common symptoms include:

* Elevated body temperature
* Chills
* Sweating
* Headache
* Muscle aches
* Fatigue
* Loss of appetite

In some cases, fever can be a sign of a serious underlying condition, such as pneumonia, meningitis, or sepsis. It is important to seek medical attention if you or someone in your care has a fever, especially if it is accompanied by other symptoms such as difficulty breathing, confusion, or chest pain.

Treatment for fever depends on the underlying cause and the severity of the symptoms. In some cases, medication such as acetaminophen (paracetamol) or ibuprofen may be prescribed to help reduce the fever. It is important to follow the recommended dosage instructions carefully and to consult with a healthcare professional before giving medication to children.

In addition to medication, there are other ways to help manage fever symptoms at home. These include:

* Drinking plenty of fluids to stay hydrated
* Taking cool baths or using a cool compress to reduce body temperature
* Resting and avoiding strenuous activities
* Using over-the-counter pain relievers, such as acetaminophen (paracetamol) or ibuprofen, to help manage headache and muscle aches.

Preventive measures for fever include:

* Practicing good hygiene, such as washing your hands frequently and avoiding close contact with people who are sick
* Staying up to date on vaccinations, which can help prevent certain infections that can cause fever.

A disease that affects pigs, including viral, bacterial, and parasitic infections, as well as genetic disorders and nutritional deficiencies. Some common swine diseases include:

1. Porcine Reproductive and Respiratory Syndrome (PRRS): A highly contagious viral disease that can cause reproductive failure, respiratory problems, and death.
2. Swine Influenza: A viral infection similar to human influenza, which can cause fever, coughing, and pneumonia in pigs.
3. Erysipelas: A bacterial infection that causes high fever, loss of appetite, and skin lesions in pigs.
4. Actinobacillosis: A bacterial infection that can cause pneumonia, arthritis, and abscesses in pigs.
5. Parasitic infections: Such as gastrointestinal parasites like roundworms and tapeworms, which can cause diarrhea, anemia, and weight loss in pigs.
6. Scrapie: A degenerative neurological disorder that affects pigs and other animals, causing confusion, aggression, and eventually death.
7. Nutritional deficiencies: Such as a lack of vitamin E or selenium, which can cause a range of health problems in pigs, including muscular dystrophy and anemia.
8. Genetic disorders: Such as achondroplasia, a condition that causes dwarfism and deformities in pigs.
9. Environmental diseases: Such as heat stress, which can cause a range of health problems in pigs, including respiratory distress and death.

It's important to note that many swine diseases have similar symptoms, making accurate diagnosis by a veterinarian essential for effective treatment and control.

In near drowning, the individual experiences respiratory distress and may cough up frothy liquid, which can be a sign of pulmonary edema (fluid accumulation in the lungs). This condition is caused by water entering the airways and alveoli (small air sacs in the lungs) during submersion.

While near drowning can be a life-threatening emergency, it is different from drowning, which occurs when a person experiences irreversible brain damage or death due to lack of oxygen. In near drowning, there is no evidence of severe brain injury or death.

Treatment for near drowning typically involves supportive care, such as oxygen therapy and mechanical ventilation, as well as management of any underlying respiratory or cardiac conditions. In severe cases, hospitalization may be required to monitor and treat the individual.

In adults, RDS is less common than in newborns but can still occur in certain situations. These include:

* Sepsis (a severe infection that can cause inflammation throughout the body)
* Pneumonia or other respiratory infections
* Injury to the lung tissue, such as from a car accident or smoke inhalation
* Burns that cover a large portion of the body
* Certain medications, such as those used to treat cancer or autoimmune disorders.

Symptoms of RDS in adults can include:

* Shortness of breath
* Rapid breathing
* Chest tightness or pain
* Low oxygen levels in the blood
* Blue-tinged skin (cyanosis)
* Confusion or disorientation

Diagnosis of RDS in adults is typically made based on a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood gas analysis. Treatment may involve oxygen therapy, mechanical ventilation (a machine that helps the patient breathe), and medications to help increase surfactant production or reduce inflammation in the lungs. In severe cases, a lung transplant may be necessary.

Prevention of RDS in adults includes avoiding exposure to risk factors such as smoking and other pollutants, maintaining good overall health, and seeking prompt medical attention if any respiratory symptoms develop.

RSV infections can cause a range of symptoms, including:

* Runny nose
* Decreased appetite
* Coughing
* Sneezing
* Wheezing
* Apnea (pauses in breathing)
* Blue-tinged skin and lips (cyanosis)
* Fever
* Inflammation of the lower respiratory tract (bronchiolitis)
* Pneumonia

In severe cases, RSV infections can lead to hospitalization and may require oxygen therapy or mechanical ventilation. In rare cases, RSV infections can be life-threatening, particularly in premature babies and infants with underlying medical conditions.

There is no specific treatment for RSV infections, but antiviral medications may be prescribed in severe cases. Treatment focuses on relieving symptoms and managing the infection, such as providing hydration and nutrition, administering oxygen therapy, and monitoring vital signs.

Prevention measures for RSV infections include:

* Frequent handwashing, especially after contact with an infected person or their secretions
* Avoiding close contact with anyone who has RSV infection
* Keeping children home from school or daycare if they are showing symptoms of RSV infection
* Practicing good hygiene, such as avoiding sharing utensils or personal items with anyone who is infected

There is currently no vaccine available to protect against RSV infections, but researchers are working on developing one.

Cattle diseases refer to any health issues that affect cattle, including bacterial, viral, and parasitic infections, as well as genetic disorders and environmental factors. These diseases can have a significant impact on the health and productivity of cattle, as well as the livelihoods of farmers and ranchers who rely on them for their livelihood.

Types of Cattle Diseases

There are many different types of cattle diseases, including:

1. Bacterial diseases, such as brucellosis, anthrax, and botulism.
2. Viral diseases, such as bovine viral diarrhea (BVD) and bluetongue.
3. Parasitic diseases, such as heartwater and gapeworm.
4. Genetic disorders, such as polledness and cleft palate.
5. Environmental factors, such as heat stress and nutritional deficiencies.

Symptoms of Cattle Diseases

The symptoms of cattle diseases can vary depending on the specific disease, but may include:

1. Fever and respiratory problems
2. Diarrhea and vomiting
3. Weight loss and depression
4. Swelling and pain in joints or limbs
5. Discharge from the eyes or nose
6. Coughing or difficulty breathing
7. Lameness or reluctance to move
8. Changes in behavior, such as aggression or lethargy

Diagnosis and Treatment of Cattle Diseases

Diagnosing cattle diseases can be challenging, as the symptoms may be similar for different conditions. However, veterinarians use a combination of physical examination, laboratory tests, and medical history to make a diagnosis. Treatment options vary depending on the specific disease and may include antibiotics, vaccines, anti-inflammatory drugs, and supportive care such as fluids and nutritional supplements.

Prevention of Cattle Diseases

Preventing cattle diseases is essential for maintaining the health and productivity of your herd. Some preventative measures include:

1. Proper nutrition and hydration
2. Regular vaccinations and parasite control
3. Sanitary living conditions and frequent cleaning
4. Monitoring for signs of illness and seeking prompt veterinary care if symptoms arise
5. Implementing biosecurity measures such as isolating sick animals and quarantining new animals before introduction to the herd.

It is important to work closely with a veterinarian to develop a comprehensive health plan for your cattle herd, as they can provide guidance on vaccination schedules, parasite control methods, and disease prevention strategies tailored to your specific needs.

Conclusion
Cattle diseases can have a significant impact on the productivity and profitability of your herd, as well as the overall health of your animals. It is essential to be aware of the common cattle diseases, their symptoms, diagnosis, treatment, and prevention methods to ensure the health and well-being of your herd.

By working closely with a veterinarian and implementing preventative measures such as proper nutrition and sanitary living conditions, you can help protect your cattle from disease and maintain a productive and profitable herd. Remember, prevention is key when it comes to managing cattle diseases.

The term cough is used to describe a wide range of symptoms that can be caused by various conditions affecting the respiratory system. Coughs can be classified as either dry or productive, depending on whether they produce mucus or not. Dry coughs are often described as hacking, barking, or non-productive, while productive coughs are those that bring up mucus or other substances from the lungs or airways.

Causes of Cough:

There are many potential causes of cough, including:

* Upper respiratory tract infections such as the common cold and influenza
* Lower respiratory tract infections such as bronchitis and pneumonia
* Allergies, including hay fever and allergic rhinitis
* Asthma and other chronic lung conditions
* Gastroesophageal reflux disease (GERD), which can cause coughing due to stomach acid flowing back up into the throat
* Environmental factors such as smoke, dust, and pollution
* Medications such as ACE inhibitors and beta blockers.

Symptoms of Cough:

In addition to the characteristic forceful expulsion of air from the lungs, coughs can be accompanied by a range of other symptoms that may include:

* Chest tightness or discomfort
* Shortness of breath or wheezing
* Fatigue and exhaustion
* Headache
* Sore throat or hoarseness
* Coughing up mucus or other substances.

Diagnosis and Treatment of Cough:

The diagnosis and treatment of cough will depend on the underlying cause. In some cases, a cough may be a symptom of a more serious condition that requires medical attention, such as pneumonia or asthma. In other cases, a cough may be caused by a minor infection or allergy that can be treated with over-the-counter medications and self-care measures.

Some common treatments for cough include:

* Cough suppressants such as dextromethorphan or pholcodine to relieve the urge to cough
* Expectorants such as guaifenesin to help loosen and clear mucus from the airways
* Antihistamines to reduce the severity of allergic reactions and help relieve a cough.
* Antibiotics if the cough is caused by a bacterial infection
* Inhalers and nebulizers to deliver medication directly to the lungs.

It is important to note that while cough can be a symptom of a serious condition, it is not always necessary to see a doctor for a cough. However, if you experience any of the following, you should seek medical attention:

* A persistent and severe cough that lasts for more than a few days or weeks
* A cough that worsens at night or with exertion
* Coughing up blood or mucus that is thick and yellow or greenish in color
* Shortness of breath or chest pain
* Fever, chills, or body aches that are severe or persistent.

It is also important to note that while over-the-counter medications can provide relief from symptoms, they may not address the underlying cause of the cough. If you have a persistent or severe cough, it is important to see a doctor to determine the cause and receive proper treatment.

Respiratory aspiration can lead to a range of complications, including pneumonia, bronchitis, and lung abscesses. It can also cause respiratory failure, which can be life-threatening.

Symptoms of respiratory aspiration may include coughing, wheezing, difficulty breathing, and fever. Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or endoscopy. Treatment may involve antibiotics for any infections that have developed, as well as supportive care to help the individual breathe more easily. In severe cases, respiratory aspiration may require hospitalization and mechanical ventilation.

Preventing respiratory aspiration is important, especially for individuals who are at high risk. This can involve modifications to their diet, such as thickening liquids or pureeing foods, as well as using specialized feeding tubes or devices that help to prevent the entry of foreign substances into the respiratory tract.

In the medical field, this term is used to describe a specific type of pneumonia that affects calves and is caused by a virus. It is an enzootic disease, meaning it is commonly found in certain populations or areas and can be transmitted between animals. The symptoms of this condition can include fever, coughing, difficulty breathing, and nasal discharge. Treatment typically involves the use of antibiotics, supportive care, and isolation of the affected animal to prevent the spread of the disease to other calves.

Some common examples of critical illnesses include:

1. Sepsis: a systemic inflammatory response to an infection that can lead to organ failure and death.
2. Cardiogenic shock: a condition where the heart is unable to pump enough blood to meet the body's needs, leading to serious complications such as heart failure and death.
3. Acute respiratory distress syndrome (ARDS): a condition where the lungs are severely inflamed and unable to provide sufficient oxygen to the body.
4. Multi-system organ failure: a condition where multiple organs in the body fail simultaneously, leading to serious complications and death.
5. Trauma: severe physical injuries sustained in an accident or other traumatic event.
6. Stroke: a sudden interruption of blood flow to the brain that can lead to permanent brain damage and death.
7. Myocardial infarction (heart attack): a blockage of coronary arteries that supply blood to the heart, leading to damage or death of heart muscle cells.
8. Pulmonary embolism: a blockage of the pulmonary artery, which can lead to respiratory failure and death.
9. Pancreatitis: inflammation of the pancreas that can lead to severe abdominal pain, bleeding, and organ failure.
10. Hypovolemic shock: a condition where there is a severe loss of blood or fluid from the body, leading to hypotension, organ failure, and death.

The diagnosis and treatment of critical illnesses require specialized knowledge and skills, and are typically handled by intensive care unit (ICU) teams consisting of critical care physicians, nurses, and other healthcare professionals. The goal of critical care is to provide life-sustaining interventions and support to patients who are critically ill until they recover or until their condition stabilizes.

Psittacosis is a zoonotic disease, meaning it can be transmitted between animals and humans. It is important to take precautions when handling birds or their droppings to avoid infection. Treatment of psittacosis typically involves antibiotics, and early diagnosis and treatment can help prevent complications and improve outcomes.

Psittacosis is a rare disease, but it is important for veterinarians, avian specialists, and other professionals who work with birds to be aware of the risk of transmission and take appropriate precautions to protect themselves and others.

[Term]

Empyema, Pleural

[Definition]

A condition characterized by the accumulation of pus in the pleural space between the lungs and chest wall, caused by bacterial infection or other inflammatory conditions. Symptoms include fever, chest pain, coughing, and difficulty breathing. Treatment involves antibiotics, drainage of pus, and supportive care.

[Origin]

From the Greek words "empyema" meaning "into the pleura" and "pleural" referring to the space between the lungs and chest wall.

[Types]

There are several types of empyema, including:

1. Pyogenic empyema: caused by bacterial infection, most commonly with Staphylococcus aureus.
2. Tubercular empyema: caused by tuberculosis infection.
3. Cat-scratch empyema: caused by bacteria entering the pleural space through a scratch or wound.
4. Hemorrhagic empyema: caused by bleeding into the pleural space.

[Symptoms]

Symptoms of empyema may include:

1. Fever
2. Chest pain that worsens with deep breathing or coughing
3. Coughing up pus or blood
4. Difficulty breathing
5. Fatigue
6. Loss of appetite

[Diagnosis]

Empyema is diagnosed through a combination of physical examination, chest x-ray, and pleural fluid analysis. A chest x-ray can confirm the presence of pus in the pleural space, while pleural fluid analysis can identify the type of bacteria or other infectious agents present.

[Treatment]

Treatment of empyema typically involves antibiotics to eradicate the underlying infection and drainage of the pleural fluid. In some cases, surgical intervention may be necessary to remove infected tissue or repair damaged lung tissue.

[Prognosis]

The prognosis for empyema depends on the severity of the infection and the promptness and effectiveness of treatment. With prompt and appropriate treatment, the majority of patients with empyema can recover fully. However, delays in diagnosis and treatment can lead to serious complications, including respiratory failure, sepsis, and death.

[Prevention]

Preventing the development of empyema requires prompt and effective management of underlying conditions such as pneumonia, tuberculosis, or other respiratory infections. Vaccination against Streptococcus pneumoniae and other bacteria that can cause empyema may also be recommended.

[Conclusion]

Empyema is a potentially life-threatening condition that requires prompt and appropriate treatment to prevent serious complications and improve outcomes. Awareness of the risk factors, symptoms, diagnosis, and treatment options for empyema can help healthcare providers provide effective care for patients with this condition.

Some common types of connective tissue diseases include:

1. Rheumatoid arthritis (RA): A chronic autoimmune disorder that causes inflammation and joint damage.
2. Systemic lupus erythematosus (SLE): An autoimmune disorder that can affect multiple systems in the body, including the skin, joints, and kidneys.
3. Sjogren's syndrome: An autoimmune disorder that causes dry eyes and mouth, as well as joint pain and swelling.
4. Fibromyalgia: A chronic condition characterized by widespread muscle pain and fatigue.
5. Myositis: Inflammatory diseases that affect the muscles, such as dermatomyositis and polymyositis.
6. Giant cell arteritis: A condition that causes inflammation of the blood vessels, particularly in the head and neck.
7. Takayasu arteritis: A condition that causes inflammation of the blood vessels in the aorta and its branches.
8. Polyarteritis nodosa: A condition that causes inflammation of the blood vessels, particularly in the hands and feet.
9. IgG4-related disease: A condition characterized by inflammation and damage to various organs, including the pancreas, salivary glands, and liver.

Connective tissue diseases can cause a wide range of symptoms, including joint pain and stiffness, fatigue, skin rashes, fever, and weight loss. Treatment options vary depending on the specific disease and its severity, but may include medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs). In some cases, surgery or physical therapy may also be necessary.

Staphylococcal infections can be classified into two categories:

1. Methicillin-Resistant Staphylococcus Aureus (MRSA) - This type of infection is resistant to many antibiotics and can cause severe skin infections, pneumonia, bloodstream infections and surgical site infections.

2. Methicillin-Sensitive Staphylococcus Aureus (MSSA) - This type of infection is not resistant to antibiotics and can cause milder skin infections, respiratory tract infections, sinusitis and food poisoning.

Staphylococcal infections are caused by the Staphylococcus bacteria which can enter the body through various means such as:

1. Skin cuts or open wounds
2. Respiratory tract infections
3. Contaminated food and water
4. Healthcare-associated infections
5. Surgical site infections

Symptoms of Staphylococcal infections may vary depending on the type of infection and severity, but they can include:

1. Skin redness and swelling
2. Increased pain or tenderness
3. Warmth or redness in the affected area
4. Pus or discharge
5. Fever and chills
6. Swollen lymph nodes
7. Shortness of breath

Diagnosis of Staphylococcal infections is based on physical examination, medical history, laboratory tests such as blood cultures, and imaging studies such as X-rays or CT scans.

Treatment of Staphylococcal infections depends on the type of infection and severity, but may include:

1. Antibiotics to fight the infection
2. Drainage of abscesses or pus collection
3. Wound care and debridement
4. Supportive care such as intravenous fluids, oxygen therapy, and pain management
5. Surgical intervention in severe cases.

Preventive measures for Staphylococcal infections include:

1. Good hand hygiene practices
2. Proper cleaning and disinfection of surfaces and equipment
3. Avoiding close contact with people who have Staphylococcal infections
4. Covering wounds and open sores
5. Proper sterilization and disinfection of medical equipment.

It is important to note that MRSA (methicillin-resistant Staphylococcus aureus) is a type of Staphylococcal infection that is resistant to many antibiotics, and can be difficult to treat. Therefore, early diagnosis and aggressive treatment are crucial to prevent complications and improve outcomes.

Some common types of Chlamydophila infections include:

1. Pneumonia: Chlamydophila pneumoniae can cause pneumonia, which is an inflammation of the lungs that can lead to fever, cough, chest pain, and difficulty breathing.
2. Trachoma: Chlamydia trachomatis can cause trachoma, a highly contagious eye infection that can lead to blindness if left untreated.
3. Pelvic inflammatory disease (PID): Chlamydia trachomatis and Chlamydia psittaci can cause PID, an infection of the female reproductive organs that can lead to chronic pelvic pain, infertility, and ectopic pregnancy.
4. Urinary tract infections (UTIs): Chlamydia trachomatis and Chlamydia caviae can cause UTIs, which are infections of the urinary tract that can lead to symptoms such as burning during urination and frequent urination.
5. Rectal infections: Chlamydia trachomatis and Chlamydia psittaci can cause rectal infections, which can lead to symptoms such as rectal pain, bleeding, and discharge.

Chlamydophila infections are typically treated with antibiotics, and early treatment can help prevent long-term complications and reduce the risk of transmission to others. It is important to practice safe sex and good hygiene to prevent the spread of these infections.

Pulmonary aspergillosis is a type of fungal infection that affects the lungs and is caused by the fungus Aspergillus. It can occur in people with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive drugs following an organ transplant.

The symptoms of pulmonary aspergillosis can vary depending on the severity of the infection and may include:

* Coughing up blood or mucus
* Chest pain or tightness
* Fever
* Shortness of breath
* Chills
* Weight loss

In severe cases, pulmonary aspergillosis can lead to respiratory failure, which can be life-threatening.

Pulmonary aspergillosis is diagnosed through a combination of imaging tests such as chest X-rays, CT scans, and fungal cultures. Treatment typically involves antifungal medications and supportive care to manage symptoms and prevent complications. In severe cases, hospitalization may be necessary to provide oxygen therapy and other respiratory support.

Prevention is key in avoiding pulmonary aspergillosis, especially for individuals with weakened immune systems. This includes avoiding exposure to fungal spores, managing underlying health conditions, and taking antifungal medications as prescribed. Early diagnosis and treatment can significantly improve outcomes for those affected by this condition.

... seen by ultrasound Pneumonia seen by ultrasound Pneumonia seen by ultrasound Right middle lobe pneumonia in a child ... Viral pneumonia presents more commonly with wheezing than bacterial pneumonia. Pneumonia was historically divided into "typical ... X-ray presentations of pneumonia may be classified as lobar pneumonia, bronchopneumonia, lobular pneumonia, and interstitial ... bronchial pneumonia and acute interstitial pneumonia; or by the causative organism. Pneumonia in children may additionally be ...
"Aspiration Pneumonitis and Pneumonia: Overview of Aspiration Pneumonia, Predisposing Conditions for Aspiration Pneumonia, ... In the elderly, dysphagia is a significant risk factor for the development of aspiration pneumonia. Aspiration pneumonia most ... Individuals diagnosed with aspiration pneumonia were also at increased risk of developing future episodes of pneumonia. In fact ... Additionally, it is difficult to distinguish between aspiration pneumonia and aspiration pneumonitis. Aspiration pneumonia is ...
... , also known as walking pneumonia, is any type of pneumonia not caused by one of the pathogens most commonly ... This is occult pneumonia. In general, occult pneumonia is rather often present in patients with pneumonia and can also be ... "Pneumonia". National Heart, Lung and Blood Institute. What Is Walking Pneumonia? Walking pneumonia: What does it mean? Memish ... "Atypical Pneumonia (Walking Pneumonia)". Cleveland Clinic. Walter C, McCoy MD (1946). "Primary atypical pneumonia: A report of ...
... (also known as "walking pneumonia") is a form of bacterial pneumonia caused by the bacterial species ... Mycoplasmal pneumonia of swine Waris ME, Toikka P, Saarinen T, et al. (November 1998). "Diagnosis of Mycoplasma pneumoniae ... It is also known as PPLO, which is an acronym for Pleuro Pneumonia Like Organism. Mycoplasma pneumoniae is spread through ... The infection caused by this bacterium is called atypical pneumonia because of its protracted course and lack of sputum ...
Acute eosinophilic pneumonia was first described in 1989. Asthma Parasitic pneumonia Pneumonia Bain GA, Flower CD (1996). " ... Acute eosinophilic pneumonia has been associated with smoking. Chronic eosinophilic pneumonia occurs more frequently in women ... When a cause cannot be found, the eosinophilic pneumonia is termed "idiopathic". Idiopathic eosinophilic pneumonia can also be ... Eosinophilic pneumonia is a disease in which an eosinophil, a type of white blood cell, accumulates in the lungs. These cells ...
A form of pneumonia, dust pneumonia results when the lungs are filled with dust, inflaming the alveoli.[citation needed] ... Symptoms of dust pneumonia include high fever, chest pain, difficulty in breathing, and coughing. With dust pneumonia, dust ... Dust pneumonia was featured in the work of several musicians and artists of the day, such as Woody Guthrie's song "Dust ... Dust pneumonia describes disorders caused by excessive exposure to dust storms, particularly during the Dust Bowl in the United ...
... (NP), also known as cavitary pneumonia or cavitatory necrosis, is a rare but severe complication of lung ... "Necrotising pneumonia is an increasingly detected complication of pneumonia in children". European Respiratory Journal. 31 (6 ... Necrotizing pneumonia is an ancient disease which was once a leading cause of death in both adults and children. Its clinical ... In necrotizing pneumonia, there is a substantial liquefaction following death of the lung tissue, which may lead to gangrene ...
... (PCP), also known as Pneumocystis jirovecii pneumonia (PJP), is a form of pneumonia that is caused by ... pneumonia and (incorrectly) as Pneumocystis carinii pneumonia. Regarding nomenclature, when the name of Pneumocystis pneumonia ... No present-day therapeutic measures seem to be of any definite value." Both Pneumocystis pneumonia and pneumocystis pneumonia ... Bennett NJ, Gilroy SA (2017-08-08). "Pneumocystis jiroveci Pneumonia (PJP) Overview of Pneumocystis jiroveci Pneumonia". ...
... is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the ... bacterial pneumonia often complicates viral pneumonia. The best prevention against viral pneumonia is vaccination against ... Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, ... There are roughly 450 million cases of pneumonia every year. Of those case, viral pneumonia counts for about 200 million cases ...
... is a pneumonia that is not observable directly by the eye, but can only be shown indirectly, especially by ... Occult pneumonia, however, can also be the result of atypical pneumonia. Although pneumococcal vaccination lowers the ... Occult pneumonia can be made visible by chest X-rays. The general symptoms cough for more than 10 days and fever for more than ... 34 M.S. Rutman, R. Bachur, M.B. Harper Radiographic pneumonia in young, highly febrile children with leukocytosis before and ...
... is a form of pneumonia characterized by inflammatory exudate within the intra-alveolar space resulting in ... "Lobar Pneumonia". Retrieved 2008-11-16. Media related to Lobar pneumonia at Wikimedia Commons (Articles with short description ... Like other types of pneumonia, lobar pneumonia can present as community acquired, in immune suppressed patients or as ... It is one of three anatomic classifications of pneumonia (the other being bronchopneumonia and atypical pneumonia). In children ...
... is an infection of the lungs by parasites.[better source needed] It is a rare cause of pneumonia, occurring ... "Parasitic Pneumonia and Lung Involvement". BioMed Research International. 2014: 874021. doi:10.1155/2014/874021. ISSN 2314-6133 ... Ascaris Schistosoma Toxoplasma gondii Pneumonia Cheepsattayakorn, Attapon; Cheepsattayakorn, Ruangrong (2014). " ...
Look up pneumonia in Wiktionary, the free dictionary. Pneumonia is an inflammatory condition of the lung in humans. This may ... the condition above but in animals Pneumonia front, a rare meteorological phenomenon on western Lake Michigan Pneumonia (album ... This disambiguation page lists articles associated with the title Pneumonia. If an internal link led you here, you may wish to ...
... (white pneumonia) is often seen in neonates with congenital syphilis. The lung may be firm and pale, owing to ...
Pneumonia Fever Rigors Cough Runny nose (either direct bacterial pneumonia or accompanied by primary viral pneumonia) Dyspnea ... Bacterial pneumonia is a type of pneumonia caused by bacterial infection. Streptococcus pneumoniae (J13) is the most common ... Pneumonia caused by Yersinia pestis is usually called pneumonic plague. Atypical bacteria causing pneumonia are Coxiella ... The antibiotic choice depends on the nature of the pneumonia, the microorganisms most commonly causing pneumonia in the ...
... can be treated with antifungal drugs and sometimes by surgical debridement. Pneumonia Meersseman W, Lagrou K, ... In a very small portion of people, fungal pneumonia can lead to chronic pneumonia, fungemia (presence of fungi in the blood), ... Fungal Pneumonia: a silent epidemic , CDC PDF www.cdc.gov/fungal/pdf/cocci-fact-sheet-sw-us-508c.pdf Morrell M, Fraser VJ, ... Fungal pneumonia is an infection of the lungs by fungi. It can be caused by either endemic or opportunistic fungi or a ...
A pneumonia jacket was a medical device used to warm the chest of a person with pneumonia. In the pre-antibiotic era, ... Pneumonia jackets were variously constructed of oiled silk, muslin, and sometimes even included a system of rubber tubing that ... Ingraham, Charles (May 18, 1895). "Further report on the treatment of acute lobar pneumonia by the continuous application of a ... CS1: Julian-Gregorian uncertainty, Articles with short description, Short description matches Wikidata, Pneumonia, Medical ...
Lipoid pneumonia is a specific form of lung inflammation (pneumonia) that develops when lipids enter the bronchial tree. The ... The pneumonia presents as a foreign body reaction causing cough, dyspnea, and often fever. Hemoptysis has also been reported. ... The gross appearance of a lipid pneumonia is that in which there is an ill-defined, pale yellow area on the lung. This yellow ... Lipid pneumonia has been known to occur in underwater divers after breathing poorly filtered air supplied by a surface ...
Can officially label this a Pneumonia Front. #wiwx". 17 June 2022. "Synoptic and Local Controls of the Lake Michigan Pneumonia ... The term Pneumonia front, first coined by the National Weather Service in Milwaukee in the 1960s, is used to describe a rare ... Pneumonia fronts are most common between the months of April to July when the temperature difference between the cold lake ... "Brace for the 'pneumonia front:' Skilling says jarring 20-30 degree temp drop to hit tonight". 29 September 2014. "FOX6 Weather ...
... is a type of bacterial pneumonia that is caused by Streptococcus pneumoniae (pneumococcus). It is the ... "Pneumonia Causes - Mayo Clinic". www.mayoclinic.org. Retrieved 2016-04-26. "Flu Infection Needed to Allow Spread of Pneumonia ... "Pneumococcal Pneumonia". www.niaid.nih.gov. Retrieved 2016-04-26. "Pneumococcal Disease , Facts About Pneumonia , CDC". www.cdc ... A vaccine has been developed for the prevention of pneumococcal pneumonia, recommended to children under age five as well as ...
"Pneumonia". AllMusic. Retrieved 2018-02-27. Hernandez, Raoul (2001-06-08). "Whiskeytown Pneumonia (Lost Highway)". The Austin ... Pneumonia is the third and final studio album by the alternative country band Whiskeytown, released on May 22, 2001 on Lost ... Pneumonia (Media notes). Whiskeytown. Universal City, CA: UMG Recordings, Inc. 2001. 088 170 199-2.{{cite AV media notes}}: CS1 ... By the time we went to make Pneumonia, there were only three surviving members. Everybody kind of pooled thoughts together for ...
... (DIP) is a form of idiopathic interstitial pneumonia featuring elevated numbers of ... v t e (Articles with short description, Short description is different from Wikidata, Histopathology, Pneumonia, All stub ... Godbert, Benoît; Wissler, Marie-Pierre; Vignaud, Jean-Michel (2013-06-01). "Desquamative interstitial pneumonia: an analytic ... December 1999). "Increasing dose of methylprednisolone pulse therapy treats desquamative interstitial pneumonia in a child". ...
... , also known as mycoplasmal pneumonia, is a chronic respiratory disease of pigs caused by Mycoplasma ... This may lead to signs of pneumonia and systemic involvement. Diagnosis relies on culture and isolation of the bacteria but ... "Enzootic Pneumonia - Pigs - WikiVet English". WikiVet. 3 August 2011. Retrieved 2018-03-10. (Articles lacking in-text citations ... Mycoplasmal pneumonia". Modern Livestock & Poultry Production (9th ed.). Cengage Learning. p. 437. ISBN 9781305483156. " ...
... bronchiolitis obliterans interstitial pneumonia; OP=organizing pneumonia; LIP=lymphoid interstitial pneumonia; LPD= ... Idiopathic interstitial pneumonia (IIP), or noninfectious pneumonia are a class of diffuse lung diseases. These diseases ... Table 1: Development of the (histologic) idiopathic interstitial pneumonia classification UIP=usual interstitial pneumonia; DAD ... diffuse alveolar damage; NSIP=non-specific interstitial pneumonia; DIP=desquamative interstitial pneumonia; RB=respiratory ...
... (12 November) provides an annual forum for the world in the fight against pneumonia. More than 100 ... The Global Action Plan for the Prevention and Control of Pneumonia (GAPP) released by the WHO and UNICEF on World Pneumonia Day ... This makes pneumonia the number 1 killer of children under 5, claiming more lives in this age group than AIDS, malaria, and ... Malaria & Pneumonia, the Global Health Council, the GAVI Alliance, and the Sabin Vaccine Institute joined together in a call to ...
The pneumonia caused by Tuberculous appears more often in dogs. Gastric acid can also trigger pneumonia when a pet is throwing ... "Pneumonia". Metropolitan Veterinary Associates. Retrieved 2021-12-18. "Pneumonia in Small Animals - Respiratory System". MSD ... Pneumonia is an irritation of the lungs caused by different sources. It is characterized by an inflammation of the deep lung ... Pneumonia can be acute or chronic. This life-threatening illness is more common in cats than in dogs and the complication " ...
... is a set of pneumonia-like symptoms that occur with no sign of infection in the lung. Idiopathic ... Idiopathic pneumonia syndrome entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain ... The symptoms are like pneumonia, and include fever, chills, coughing, and breathing problems. Lack of oxygen may also occur. ... Klein, Orly; Cooke, Kenneth (2015). "Idiopathic pneumonia syndrome following hematopoietic stem cell transplantation". Journal ...
... (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at ... Healthcare-associated pneumonia can be defined as pneumonia in a patient with at least one of the following risk factors: ... Ventilator-associated pneumonia (VAP) is a sub-type of hospital-acquired pneumonia (HAP) which occurs in people who are ... Pneumonia occurs more often in people who are using a respirator. This machine helps them breathe. Hospital-acquired pneumonia ...
... applies to disorders associated with both monoclonal or polyclonal gammopathy. Patients with ... Lymphocytic interstitial pneumonia (LIP) is a syndrome secondary to autoimmune and other lymphoproliferative disorders. ... Possible causes of lymphocytic interstitial pneumonia include the Epstein-Barr virus, auto-immune, and HIV. Arterial blood ... ISBN 978-0-323-46119-1. Teirstein AS, Rosen MJ (September 1988). "Lymphocytic interstitial pneumonia". Clin. Chest Med. 9 (3): ...
... is the acute-onset form of eosinophilic pneumonia, a lung disease caused by the buildup of ... "Acute Eosinophilic Pneumonia - NORD (National Organization for Rare Disorders)". Retrieved 2015-09-21. (Articles with short ...
Pneumocystis pneumonia (PCP) is a serious illness caused by the fungus Pneumocystis jirovecii. PCP is one of the most frequent ... How Pneumocystis pneumonia Spreads. PCP spreads from person to person through the air. 15-17 Some healthy adults can carry the ... Pneumocystis jirovecii pneumonia in patients with or without AIDS, Franceexternal icon. Emerg Infect Dis 2014;20:1490-7. ... Pneumocystis jirovecii pneumonia: current knowledge and outstanding public health issuesexternal icon. Curr Fung Infect Rep ...
Pneumonia[majr:noexp] AND humans[mh] AND english[la] AND last 1 Year [edat] AND (patient education handout[pt] OR guideline[ ... Pneumonia[majr:noexp] AND humans[mh] AND english[la] AND last 1 Year [edat] AND (patient education handout[pt] OR guideline[ ... Novel fast pathogen diagnosis method for severe pneumonia patients in the intensive care unit: randomized clinical trial. Wang ... Deconstruction of Clinical Treatment of Pneumonia and Respiratory Tract Infection Based on MRI Molecular Imaging. Jiang L, Shen ...
The disease used to be called Pneumocystis carini or PCP pneumonia. ... Pneumocystis jiroveci pneumonia is a fungal infection of the lungs. ... Pneumocystis jiroveci pneumonia is a fungal infection of the lungs. The disease used to be called Pneumocystis carini or PCP ... This type of pneumonia is caused by the fungus Pneumocystis jiroveci. This fungus is common in the environment and rarely ...
There were significant differences between the CT patterns of patients with COVID-19 and other atypical pneumonia. The presence ... Computed tomography findings in COVID-19 and atypical pneumonia: a comparative study Esra Çıvgın 1 , İzzet Selçuk Parlak 1 , ... Computed tomography findings in COVID-19 and atypical pneumonia: a comparative study Esra Çıvgın et al. J Infect Dev Ctries. ... Conclusions: There were significant differences between the CT patterns of patients with COVID-19 and other atypical pneumonia ...
The infection is usually further categorized into community-acquired pneumonia or hospital- or healthcare-acquired pneumonia. ... More than 3 million cases of pneumonia occur annually in the United States. Defined as an infection of the lung, pneumonia can ...
Legionella Pneumonia) is caused by bacteria. You get it by breathing in mist from water that contains the bacteria. Learn more. ... Other types of pneumonia have similar symptoms. You will probably need a chest x-ray to diagnose the pneumonia. Lab tests can ... Legionnaires disease is a type of pneumonia caused by bacteria. You usually get it by breathing in mist from water that ...
Pneumonia is a lung infection that causes your air sacs to fill up with fluid or pus. Learn about how pneumonia is treated. ... Treatment for pneumonia depends on your risk factors and how serious your pneumonia is. Many people who have pneumonia are ... If you stop too soon, your pneumonia may come back.. *Antiviral medicine is sometimes prescribed for viral pneumonia. However, ... If your pneumonia is very serious, you may need to be put on a ventilator. ...
... : Proportionate mortality ratio (PMR) adjusted for age, sex, and race by usual industry, U.S. ... Pneumonia and/or influenza: Proportionate mortality ratio (PMR) adjusted for age, sex, and race by usual occupation, U.S. ... Pneumonia and Influenza: Proportionate mortality ratio (PMR) adjusted for age, sex, and race by NORA industrial sector, U.S. ...
Centers for Disease Control and Prevention ...
Pneumonia is an inflammatory pulmonary process that may originate in the lung or be a focal complication of a contiguous or ... Postnatal pneumonia. Postnatal pneumonia in the first 24 hours of life originates after the infant has left the birth canal. It ... True congenital pneumonia. True congenital pneumonia is already established at birth. It may become established long before ... Intrapartum pneumonia. Intrapartum pneumonia is acquired during passage through the birth canal. It may be acquired via ...
... cooking stoves with chimneys lowered exposure to wood smoke from open cooking fires and reduced the rate of severe pneumonia by ... Childhood deaths from pneumonia are relatively uncommon in the United States. But the disease kills more children worldwide ... "We found as large a benefit for severe pneumonia as more well-known public health interventions, such as vaccinations and ... The researchers saw a significantly reduction in severe childhood pneumonia in households with a chimney stove. The people in ...
... pneumonia - Sharing our stories on preparing for and responding to public health events ...
BACTERIAL PNEUMONIA * Etiologic Agents The reported distribution of etiologic agents that cause nosocomial pneumonia differs ... VIRAL PNEUMONIAS Viruses can be an important and often unappreciated cause of nosocomial pneumonia (538-540). In one ... Analyses of pneumonia-associated morbidity have indicated that pneumonia could prolong hospitalization by 4-9 days (79-83); in ... Risk factors for nosocomial pneumonia in the elderly. Am J Med 1992;92:161-6. * Kollef MH. Ventilator-associated pneumonia: a ...
JavaScript is disabled for your browser. Some features of this site may not work without it ...
... r Children Infected with Human Immunodeficiency Virus ... al, Pneumocystis carinii pneumonia (PCP) in low-risk HIV infected children (Abstract 108) Pediatr Res 1990;27:183a. * Scott G ... Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes ... Pneumocystis carinii pneumonia is the most common serious HIV-associated opportunistic infection among children. PCP was ...
Pneumocystis carinii pneumonia in a previously healthy infant. Palazzi DL, Edwards MS. Palazzi DL, et al. Semin Pediatr Infect ... Pneumocystis carinii pneumonia. Charles MA, Schwarz MI. Charles MA, et al. Postgrad Med. 1973 Apr;53(4):86-92. doi: 10.1080/ ... Pneumocystis carinii pneumonia and primary immune deficiency diseases. Walzer PD, Schultz MG, Western KA, Robbins JF. Walzer PD ... The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review. Wu ...
Klebsiella pneumonia: Epidemiology and Genomics. Download VideoCast. You can download this VideoCast and play it on your device ... Klebsiella pneumonia : epidemiology and genomics / Tara Palmore, Julie Segre, Henry Masur. Author: Palmore, Tara N. National ... CC Grand Rounds: Klebsiella pneumonia: Epidemiology and Genomics. For more information go to http://www.cc.nih.gov/about/news/ ...
Management of pneumonia in community settings. Policy documents. Global action plan for prevention and control of pneumonia ( ... Children whose immune systems are compromised are at higher risk of developing pneumonia. Photo credit: WHOPneumonia is a form ... Pneumonia can be spread in a number of ways. The viruses and bacteria that are commonly found in a childs nose or throat, can ... Preventing pneumonia in children is an essential component of a strategy to reduce child mortality. Immunization against Hib, ...
NIEHS intramural scientists have defined descriptive terms of particular relevance to their own research, and have ranked those terms accordingly. This search feature obtains best-matches with the terms you choose, and shows an overall score based on the scientific rankings.. View our page to search various areas of interest and methodology.. ...
... has protected six rhesus macaques from pneumonia caused by the virus, NIH study finds. ... Investigational ChAdOx1 nCoV-19 Vaccine Protects Monkeys Against COVID-19 Pneumonia. Study Provided Data for Clinical Testing ... Single dose ChAdOx1 nCoV-19 vaccination reduces SARS-CoV-2 replication and prevents pneumonia in rhesus macaques. ... has protected six rhesus macaques from pneumonia caused by the virus, according to National Institutes of Health scientists and ...
... and other key recent findings in hospital-acquired pneumonia? Take this short quiz. ... Hospital-acquired pneumonia (HAP), also called nosocomial pneumonia, is a lower respiratory infection that presents clinically ... Severe Pneumonia Caused by Corynebacterium striatum in Adults, Seoul, South Korea, 2014-2019 1.0 CME / ABIM MOC Credits Journal ... Diagnosing and Treating Complicated Pediatric Pneumonia: Common Missteps and Best Practices * Antenatal Corticosteroids: A Life ...
Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed) RFA-HL-23-002. NHLBI ... ARDS, pneumonia, and sepsis are common critical illness syndromes with significant associated morbidity and mortality, both ... A senior PD/PI with extensive clinical research experience and expertise in the areas of ARDS, pneumonia, and/or sepsis. ... NOT-HL-21-006 - Notice of Intent to Publish a Funding Opportunity Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping ...
2013)‎. Ending preventable child deaths from pneumonia and diarrhoea by 2025 : the integrated global action plan for pneumonia ... Ending preventable child deaths from pneumonia and diarrhoea by 2025 : the integrated global action plan for pneumonia and ...
Pneumonia is an infection of the lungs, usually caused by viruses or bacteria. ... Pneumonia. Say: nuh-MOAN-ya. Pneumonia is a lung infection usually caused by viruses or bacteria. A person with pneumonia may ... A doctor can tell if someone has pneumonia by listening to their lungs or looking at a chest X-ray. Pneumonia can be serious, ...
Pneumonia, an infection of the lungs, needlessly affects millions of people worldwide each year. ... Types of Pneumonia. Community-acquired pneumonia is when someone develops pneumonia in the community (not in a hospital). ... Who Can Get Pneumonia. Certain people are more likely to become ill with pneumonia: adults 65 years or older; children younger ... Causes of Pneumonia. Viruses, bacteria, and fungi can all cause pneumonia. In the United States, common causes of viral ...
... battle with pneumonia which left him hospitalised and struggling to breathe. ... "I needed a CT scan and thats when I knew there was pneumonia in my lungs and by that time I was struggling to breathe and it ... Lyndon Dykes viewing game differently after pneumonia scare Updated / Wednesday, 22 Mar 2023 10:50 ... Lyndon Dykes has spoken of his "scary" battle with pneumonia which left him hospitalised and struggling to breathe. ...
  • Antibiotics may be prescribed for bacterial pneumonia. (nih.gov)
  • Sections on the prevention of bacterial pneumonia in mechanically ventilated and/or critically ill patients, care of respiratory-therapy devices, prevention of cross-contamination, and prevention of viral lower respiratory tract infections (e.g., respiratory syncytial virus {RSV} and influenza infections) have been expanded and updated. (cdc.gov)
  • Because intubation and mechanical ventilation alter first-line patient defenses, they greatly increase the risk for nosocomial bacterial pneumonia. (cdc.gov)
  • A common cause of bacterial pneumonia is Streptococcus pneumoniae (pneumococcus). (cdc.gov)
  • The sprinter was forced to withdraw from the Arctic Tour of Norway earlier this month with bacterial pneumonia in the right lung. (cyclingnews.com)
  • There are three main types of pneumonia-bacterial pneumonia, viral pneumonia and mycoplasma pneumonia. (childrenshospital.org)
  • Bacterial pneumonia is caused by various bacteria, most often the bacteria called streptococcus pneumoniae. (childrenshospital.org)
  • Early symptoms of viral pneumonia are the same as those of bacterial pneumonia. (childrenshospital.org)
  • Viral pneumonias may make your child susceptible to bacterial pneumonia. (childrenshospital.org)
  • Treatment may include antibiotics for bacterial pneumonia. (childrenshospital.org)
  • CHICAGO - A study published this week in the scientific journal Nature examines why COVID-19 pneumonia lasts longer and causes more damage to lung tissue than typical pneumonia. (abcactionnews.com)
  • This case is included in a report of three cases showing that intermittent adjunctive treatment with HFPV in patients with severe COVID-19 pneumonia not only improved lung function but also appeared to prevent further clinical deterioration. (medpagetoday.com)
  • Research describing the stages of COVID-19 pneumonia and patterns observed on lung CT scan has identified ground-glass opacities, intralobular and/or interlobular septal thickening, reticular pattern, consolidation, and linear opacities as occurring most frequently, with these variations occurring separately or in combination as the disease runs its course. (medpagetoday.com)
  • In a new study, published in the journal Strahlentherapie und Onkologie , researchers at the Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain, showed the potential benefit of treating COVID-19 pneumonia with ultra-low doses of radiotherapy, called ULTRA-COVID. (news-medical.net)
  • The researchers concluded that the preliminary clinical and radiological results suggest a potential benefit of COVID-19 pneumonia treatment with ULTRA-COVID. (news-medical.net)
  • Legionnaires' disease is a type of pneumonia caused by bacteria. (nih.gov)
  • Most bacterial nosocomial pneumonias occur by aspiration of bacteria colonizing the oropharynx or upper gastrointestinal tract of the patient. (cdc.gov)
  • Pneumonia is a lung infection usually caused by viruses or bacteria . (kidshealth.org)
  • Viruses, bacteria, and fungi can all cause pneumonia. (cdc.gov)
  • Bacteria and viruses that commonly cause pneumonia in the community are different from those in the healthcare settings. (cdc.gov)
  • Vaccines can help prevent infection by some of the bacteria and viruses that can cause pneumonia. (cdc.gov)
  • If bacteria caused the pneumonia, then an antibiotic may be given. (cincinnatichildrens.org)
  • Pneumonia is an inflammation of the lungs caused by bacteria, viruses or chemical irritants. (childrenshospital.org)
  • Pneumocystis jiroveci pneumonia is a fungal infection of the lungs. (medlineplus.gov)
  • Photo credit: WHO Pneumonia is a form of acute respiratory infection that affects the lungs. (who.int)
  • A doctor can tell if someone has pneumonia by listening to their lungs or looking at a chest X-ray. (kidshealth.org)
  • Globally, pneumonia (an infection of the lungs) kills more children younger than 5 years old each year than any other infectious disease, such as HIV infection, malaria, or tuberculosis. (cdc.gov)
  • Pneumonia is an infection of the lungs that can cause mild to severe illness in people of all ages. (cdc.gov)
  • I needed a CT scan and that's when I knew there was pneumonia in my lungs and by that time I was struggling to breathe and it was hard to move around. (rte.ie)
  • Pneumonia is an infection in one or both of the lungs. (smartdraw.com)
  • Pneumonia is an infection of the lungs. (cincinnatichildrens.org)
  • Smoke is very irritating to the lungs especially for someone with pneumonia. (cincinnatichildrens.org)
  • Singer says viral pneumonia, like that found in the flu, is like a burst of fire, where the lungs are inflamed for a short period of time. (abcactionnews.com)
  • The immune response to COVID pneumonia is much more like kind of a slow burn in the lungs where people are exposed to inflammation over a long period of time and that's where we see this great degree of damage. (abcactionnews.com)
  • The first-of-its-kind study compared fluid collected from the lungs of COVID-19 ICU patients with that of pneumonia patients from before the pandemic. (abcactionnews.com)
  • The major difference between coronaviruses that cause a cold and those that cause a severe illness is that the former primarily infect the upper respiratory tract (the nose and throat), whereas the latter thrive in the lower respiratory tract (the lungs) and can lead to pneumonia. (scientificamerican.com)
  • Aspiration pneumonia is an inflammation of the lungs caused by breathing in foreign material, such as food, liquid, vomit, or mucus. (healthwise.net)
  • Pneumocystis pneumonia (PCP) is a serious infection caused by the fungus Pneumocystis jirovecii . (cdc.gov)
  • Deconstruction of Clinical Treatment of Pneumonia and Respiratory Tract Infection Based on MRI Molecular Imaging. (nih.gov)
  • This revised guideline addresses common problems encountered by infection- control practitioners regarding the prevention and control of nosocomial pneumonia in U.S. hospitals. (cdc.gov)
  • Part I, 'An Overview of the Prevention of Nosocomial Pneumonia, 1994,' provides the background information for the consensus recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) in Part II, 'Recommendations for Prevention of Nosocomial Pneumonia. (cdc.gov)
  • Pneumonia is the second most common nosocomial infection in the United States and is associated with substantial morbidity and mortality. (cdc.gov)
  • Although patients receiving mechanically assisted ventilation do not represent a major proportion of patients who have nosocomial pneumonia, they are at highest risk for acquiring the infection. (cdc.gov)
  • Although guidelines have been established for prophylaxis against Pneumocystis carinii pneumonia (PCP) for adults with human immunodeficiency virus (HIV) infection, they have not been available for children (1). (cdc.gov)
  • Pneumocystis carinii pneumonia is the most common serious HIV-associated opportunistic infection among children. (cdc.gov)
  • Infants and young children may be more seriously affected than older children and adults because for the former, Pneumocystis carinii pneumonia may represent primary infection rather than reactivation disease, and because an infant's or young child's immune defenses may be immature. (cdc.gov)
  • Hospital-acquired pneumonia (HAP), also called nosocomial pneumonia, is a lower respiratory infection that presents clinically 2 or more days after hospitalization and was not incubating at the time of hospital admission. (medscape.com)
  • Many factors affect how serious pneumonia is, such as the type of germ causing the infection and your age and overall health. (smartdraw.com)
  • About 10 to 15 percent of children with a respiratory infection have pneumonia. (childrenshospital.org)
  • Researchers at Boston Children's Hospital and the Harvard T.H. Chan School of Public Health have discovered a new mechanism of immunity that suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, which leads to serious illnesses, including pneumonia and meningitis (inflammation of the brain). (childrenshospital.org)
  • People who have aspiration pneumonia are usually treated with antibiotics in a hospital to prevent or treat an infection. (healthwise.net)
  • Traditional preventive measures for nosocomial pneumonia include decreasing aspiration by the patient, preventing cross-contamination or colonization via hands of personnel, appropriate disinfection or sterilization of respiratory-therapy devices, use of available vaccines to protect against particular infections, and education of hospital staff and patients. (cdc.gov)
  • On Easter Sunday 2003, my daughter was hospitalized at Alvarado Hospital in the surgical intensive care unit with acute pancreatitis leading to pneumonia followed by a second pneumonia from aspiration. (reiki.org)
  • COVID-19 is an important novel cause of acute respiratory distress syndrome (ARDS) characterized by hypoxemic respiratory failure, most commonly due to pneumonia, sepsis, and aspiration. (medpagetoday.com)
  • Go to Pediatric Pneumonia and Afebrile Pneumonia Syndrome for more complete information on these topics. (medscape.com)
  • Immunization against Hib, pneumococcus, measles and whooping cough ( pertussis ) is the most effective way to prevent pneumonia. (who.int)
  • A person with pneumonia may have a fever and cough , and it may be hard to breathe for a little while. (kidshealth.org)
  • Common signs of pneumonia can include cough, fever, and trouble breathing. (cdc.gov)
  • Pneumonia is a heterogeneous disease with a host response that ranges from mild symptoms (fever, cough, and chest pain) to septic shock with multisystem organ failure. (nursingcenter.com)
  • Other less common pneumonias may be caused by the inhaling of food, liquid, gases or dust, or by fungi. (childrenshospital.org)
  • If your pneumonia is serious, you may be treated in a hospital so you can get antibiotics and fluids through an intravenous (IV) line inserted into your vein. (nih.gov)
  • 8. The treatment for most types of serious pneumonia is usually antibiotics, which typically cost less than $1 per dose . (one.org)
  • 9. Tragically, only an estimated 1 of every 5 children with pneumonia receives antibiotics. (one.org)
  • If a virus caused the pneumonia, antibiotics may not be necessary. (cincinnatichildrens.org)
  • Antibiotics may also speed recovery from mycoplasma pneumonia and some special cases. (childrenshospital.org)
  • Antiviral medicine is sometimes prescribed for viral pneumonia. (nih.gov)
  • In the United States, common causes of viral pneumonia are influenza and respiratory syncytial virus (RSV). (cdc.gov)
  • However, with viral pneumonia, the respiratory involvement happens slowly. (childrenshospital.org)
  • There is no clearly effective treatment for viral pneumonia, which usually clears up on its own. (childrenshospital.org)
  • Common causes of viral pneumonia are influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 (the virus that causes COVID-19). (nursingcenter.com)
  • This document updates and replaces CDC's previously published 'Guideline for Prevention of Nosocomial Pneumonia' (Infect Control 1982;3:327-33, Respir Care 1983;28:221-32, and Am J Infect Control 1983;11:230-44). (cdc.gov)
  • Novel fast pathogen diagnosis method for severe pneumonia patients in the intensive care unit: randomized clinical trial. (nih.gov)
  • Pneumocystis pneumonia in people with AIDS usually develops slowly over days to weeks or even months, and is less severe. (medlineplus.gov)
  • For moderate to severe pneumocystis pneumonia in people with HIV/AIDS, the short term use of corticosteroids has decreased the incidence of death. (medlineplus.gov)
  • A new study found that wood-burning cooking stoves with chimneys lowered exposure to wood smoke from open cooking fires and reduced the rate of severe pneumonia by 30% in children less than 18 months of age. (nih.gov)
  • The researchers saw a significantly reduction in severe childhood pneumonia in households with a chimney stove. (nih.gov)
  • However, the drop in severe pneumonia would likely result in reduced childhood mortality, the researchers say. (nih.gov)
  • We found as large a benefit for severe pneumonia as more well-known public health interventions, such as vaccinations and nutrition supplements," Smith says. (nih.gov)
  • Pneumonia and its symptoms can vary from mild to severe. (smartdraw.com)
  • We are learning new ways to care for patients with severe pneumonia largely and pandemics come over time. (abcactionnews.com)
  • Pneumocystis jirovecii , the fungus that causes Pneumocystis pneumonia . (cdc.gov)
  • People with pneumocystis pneumonia who do not have AIDS usually get sick faster and are more severely ill. (medlineplus.gov)
  • Pneumocystis pneumonia can be life threatening. (medlineplus.gov)
  • Pneumocystis pneumonia (PCP) has historically been antiretroviral drugs remain at high risk, and PCP continues one of the leading causes of disease among persons with to develop in certain groups in industrialized countries. (cdc.gov)
  • 6. The financial costs of pneumonia include hospital stays and medications , transportation to health centers, and the caretakers' inability to work or take care of other family members while they are caring for a sick child. (one.org)
  • Most of the people affected by pneumonia in the United States are adults. (cdc.gov)
  • The APS Consortium will seek to understand the heterogeneity and underlying mechanisms of critical illness syndromes and recovery, specifically in adults with ARDS, pneumonia, and/or sepsis, as well as the relationship and biological overlap among these syndromes. (nih.gov)
  • This will be accomplished through a prospective, longitudinal observational study with common data and biospecimen collection of 5,000 hospitalized adults with one or more of the following diagnoses: ARDS, pneumonia, or sepsis. (nih.gov)
  • This guide provides basic information on the different classifications and treatment of pneumonia in adults. (nursingcenter.com)
  • It is expected that approximately half of the participants discharged from the hospital will have follow-up at 3, 6, and 12 months to facilitate understanding of long-term outcomes, including biological and physiological resolution of ARDS, pneumonia, and sepsis. (nih.gov)
  • ARDS, pneumonia, and sepsis are common critical illness syndromes with significant associated morbidity and mortality, both during the acute phase and long-term. (nih.gov)
  • Complications of pneumonia may include acute hypoxic respiratory failure, sepsis, pleural effusion, and empyema. (nursingcenter.com)
  • These include acute respiratory distress syndrome (ARDS), pneumonia, and respiratory failure, which can lead to fatal outcomes in patients. (news-medical.net)
  • Create healthcare diagrams like this example called Diabetes Complications - Pneumonia in minutes with SmartDraw. (smartdraw.com)
  • Klebsiella pneumonia : epidemiology and genomics / Tara Palmore, Julie Segre, Henry Masur. (nih.gov)
  • Although pneumonia is an important cause of morbidity and mortality among newborn infants, it remains a difficult disease to identify promptly and treat. (medscape.com)
  • Preventing pneumonia in children is an essential component of a strategy to reduce child mortality. (who.int)
  • Therapy in infants with neonatal pneumonia is multifaceted and includes both antimicrobial therapy and respiratory support. (medscape.com)
  • You will probably need a chest x-ray to diagnose the pneumonia. (nih.gov)
  • Pneumonia that becomes clinically evident within 24 hours of birth may originate at three different times. (medscape.com)
  • Nasopharyngeal swabs were collected in two separate paediatric studies enrolling children clinically diagnosed with either bronchiolitis or pneumonia and tested for hMPV by polymerase chain reaction. (nih.gov)
  • You may need to be treated in the hospital or an intensive care unit (ICU) if your pneumonia is serious. (nih.gov)
  • Antifungal medicines are prescribed for fungal pneumonia. (nih.gov)
  • Cite this: Rapid Review Quiz: Hospital-Acquired Pneumonia - Medscape - Sep 15, 2022. (medscape.com)
  • A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from pneumonia caused by the virus, according to National Institutes of Health scientists and University of Oxford collaborators. (nih.gov)
  • New sections on Legionnaires disease and pneumonia caused by Aspergillus sp. (cdc.gov)
  • The disease used to be called Pneumocystis carini or PCP pneumonia. (medlineplus.gov)
  • This study aimed to explore different imaging characteristics between Coronavirus disease 2019 (COVID-19) and atypical pneumonia (non-COVID-19) on chest CT of patients admitted to the emergency department. (nih.gov)
  • Pneumonia claims more lives than any other disease in the developing world for children under the age of five. (one.org)
  • 1. Pneumonia kills more children under the age of five than any other disease, claiming a young life every 20 seconds. (one.org)
  • Mycoplasma pneumonia is caused by mycoplasmas, the smallest free-living agents of human disease. (childrenshospital.org)
  • This form of pneumonia is more common in people whose immune systems are weakened by disease or medicines. (healthwise.net)
  • Pneumonia is an inflammatory pulmonary process that may originate in the lung or be a focal complication of a contiguous or systemic inflammatory process. (medscape.com)
  • Community-acquired pneumonia is when someone develops pneumonia in the community (not in a hospital). (cdc.gov)
  • Healthcare-associated pneumonia is when someone develops pneumonia during or following a stay in a healthcare facility. (cdc.gov)
  • A team of researchers led by Dr. Kirk Smith at the University of California, Berkeley, set out to test whether lowering wood smoke exposure could reduce pneumonia in children. (nih.gov)
  • To arrive at the study findings, the researchers designed a study of Ultra-Low Doses of Therapy with Radiation Applied to COVID-19 (ULTRA-COVID) for patients who have pneumonia and who are not candidates for invasive mechanical ventilation. (news-medical.net)
  • Children whose immune systems are compromised are at higher risk of developing pneumonia. (who.int)
  • Treatment for pneumonia depends on your risk factors and how serious your pneumonia is. (nih.gov)
  • If your pneumonia is mild, your provider may prescribe medicines or suggest over-the-counter medicines to treat it at home. (nih.gov)
  • They generally cause a mild, widespread pneumonia that affects all age groups. (childrenshospital.org)
  • Addressing environmental factors such as indoor air pollution (by providing affordable clean indoor stoves, for example) and encouraging good hygiene in crowded homes also reduces the number of children who fall ill with pneumonia. (who.int)
  • 4. In fact, an estimated 98 percent of children who die of pneumonia live in developing countries. (one.org)
  • 5. Each year, there are more than 150 million episodes of pneumonia in young children in developing countries, and more than 11 million children need hospitalization for pneumonia. (one.org)
  • 7. Exclusive breastfeeding during the first six months of life is an important and easy way to help protect children from pneumonia and many other diseases. (one.org)
  • Nucleic acid detection tests demonstrated 5.3% of paediatric bronchiolitis cases were positive for hMPV RNA and 2.7% of children admitted with pneumonia tested positive for hMPV RNA. (nih.gov)
  • The presence of hMPV in New Zealand has been confirmed in two selected paediatric patient groups, namely children diagnosed with bronchiolitis and pneumonia. (nih.gov)
  • Pneumocystis carinii pneumonia and primary immune deficiency diseases. (nih.gov)
  • Your healthcare provider may prescribe some of the following medicines to treat your pneumonia at home or at the hospital, depending on how sick you are. (nih.gov)
  • Pneumonia that lands people in the ICU on life-support does tend to last longer than pneumonia that is caused by other types of bugs," said Dr. Benjamin Singer, one of the co-authors of the study and an assistant professor of pulmonary and critical care at Northwestern University's Feinberg School of Medicine. (abcactionnews.com)

No images available that match "pneumonia"